timolol has been researched along with latanoprost in 376 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (9.04) | 18.2507 |
| 2000's | 215 (57.18) | 29.6817 |
| 2010's | 107 (28.46) | 24.3611 |
| 2020's | 20 (5.32) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Alm, A | 1 |
| Greve, EL; Hoyng, PF; Rulo, AH | 1 |
| Alm, A; Friström, B; Heijl, A; Kjellgren, D; Söderström, M; Stjerschantz, J; Widengård, I | 1 |
| Nagasubramanian, S | 1 |
| Bito, LZ; Gaygi, Z; Nagy, ZT; Rácz, P; Ruzsonyi, MR | 1 |
| Stjernschantz, J; Watson, P | 1 |
| Camras, CB | 3 |
| Araie, M; Azuma, I; Kitazawa, Y; Masuda, K; Mishima, HK | 1 |
| Higginbotham, EJ | 1 |
| Friström, B | 1 |
| Alm, A; Camras, CB; Stjernschantz, J; Watson, P | 1 |
| Buckley, AR; Drance, SM; Nicolela, MT; Walman, BE | 1 |
| Diestelhorst, M; Krieglstein, GK; Roters, S | 1 |
| Alm, A; Stjernschantz, J | 1 |
| Diestelhorst, M; Krieglstein, GK; Lusky, M; Nagasubramanian, S | 1 |
| Crichton, AC; Drance, SM; Greve, EL; Hoyng, PF; Mills, RP; Rulo, AH | 1 |
| Alm, A; Greve, E; Hoyng, PF; Rulo, A; Watson, P | 1 |
| Alm, A; Camras, CB; Watson, PG | 1 |
| Olsson, K; Stjernschantz, J; Wistrand, PJ | 1 |
| Watson, PG | 1 |
| Crichton, A; Drance, SM; Mills, RP | 1 |
| Almegård, B; Diestelhorst, M | 1 |
| Camras, CB; Cioffi, GA; Higginbotham, EJ; Katz, LJ; Kaufman, PL; Krupin, T; Lustgarten, J; Minckler, D; Ritch, R; Robin, AL; Schumer, RA; Sherwood, M; Stewart, WC; Stjernschantz, J; Wax, MB; Weinreb, R; Wilensky, J; Zimmerman, T | 1 |
| Brubaker, R; Dinslage, S; McLaren, J | 1 |
| Gerdtham, U; Jönsson, L; Kobelt, G; Krieglstein, GK | 1 |
| Cantatore, F; Cardia, L; Gigante, G; Vetrugno, M | 1 |
| Carpineto, P; Ciancaglini, M; Gallenga, PE; Mastropasqua, L | 1 |
| Bucci, MG | 1 |
| Brubaker, RF; Maus, TL; Nau, C | 1 |
| Kaufman, PF | 1 |
| Gandi, S; Hudgins, AC; Konstas, AG; Maltezos, AC; Stewart, WC | 1 |
| Hudgins, AC; Pruitt, CA; Sine, C; Stewart, WC | 1 |
| Day, DG; Dubiner, HB; Holmes, KT; Sharpe, ED; Stewart, JA; Stewart, WC | 1 |
| Malecaze, F; Nordmann, JP; Rouland, JF; Söderström, M | 1 |
| Araie, M; Ishii, K | 1 |
| Emmerich, KH | 1 |
| Chua, JK; Lai, JS; Lam, DS; Leung, AT | 1 |
| Aaen, K; Kessing, SV; Prause, JU; Theodorsen, F; Thygesen, J | 1 |
| Alm, A; Widengård, I | 1 |
| Nicolela, MT; Oga, E; Susanna, R | 1 |
| Aung, T; Chan, YH; Chew, PT; Leong, JY; Wong, HT; Yip, CC | 1 |
| Diestelhorst, M | 2 |
| Autelitano, A; Bottoli, A; Invernizzi, T; Orzalesi, N; Rossetti, L | 1 |
| Baca, W; Friberg, T; Kiel, JW; Mensah, J; Remky, A; Sponsel, WE; Trigo, Y | 1 |
| Gagliuso, DJ; Podos, SM; Serle, JB; Wang, RF | 1 |
| Eriksson, GL; Lass, JH; Osterling, L; Simpson, CV | 1 |
| Gomez, ML; Honrubia, FM; Larrosa, JM; Pablo, L; Polo, V | 1 |
| Krieglstein, GK; Mietz, H; Schlötzer-Schrehardt, U; Strassfeld, C | 1 |
| Carpineto, P; Ciancaglini, M; Doronzo, E; Mastropasqua, L; Zuppardi, E | 1 |
| Cantor, LB | 1 |
| Larsson, LI | 3 |
| Anderschat, JF; Rubinfeld, RS; Weiss, HS | 1 |
| Findl, O; Georgopoulos, M; Kiss, B; Menapace, R; Petternel, V; Rainer, G | 1 |
| Bron, AM; Denis, P; Johansson, M; Nordmann, JP; Rouland, JF; Sellem, E | 1 |
| Avila, MY; Carré, DA; Civan, MM; Stone, RA | 1 |
| Azuara-Blanco, A; Dua, HS; Po, AL; Zhang, WY | 1 |
| Gressnerová, S; Oláh, Z; Veselá, A; Veselovský, J | 3 |
| Potocký, M | 1 |
| Andreanos, D; Dimitrakoulias, N; Kandarakis, A; Mylopoulos, N; Petounis, A | 1 |
| Andrew, R; Bergamini, MV; Davis, AA; Dickerson, J; Landry, T; Mallick, S; Netland, PA; Robertson, SM; Silver, L; Sullivan, EK; Weiner, A | 1 |
| Corrent, GF | 1 |
| Costagliola, C; Di Giovanni, A; Fusco, R; Incorvaia, C; Parmeggiani, F; Prete, AD | 1 |
| Fu, P; Guo, W; Li, M; Li, S; Meng, F; Peng, D; Shao, H; Sheng, Y; Sun, X; Xu, C; Yu, K; Zhu, Z | 1 |
| Cabarga Del Nozal, C; García Campos, JM; Luque Aranda, R; Silva Silva, G; Vázquez Salvi, A | 1 |
| Calissendorff, B; Grunge-Lowerud, A; Högberg, G; Sjöquist, B | 1 |
| El Sherbini, M; Flammer, J; Gekkieva, M; Haefliger, IO | 1 |
| Easthope, SE; Perry, CM | 1 |
| Konstas, AG; Lallos, NA; Leech, JN; Nakos, E; Stewart, WC; Tersis, I | 1 |
| Benozzi, J; Campanelli, JL; Nahum, LP; Rosenstein, RE | 1 |
| Dubiner, H; Feldman, R; Higginbotham, EJ; Stiles, M | 1 |
| Holló, G; Kóthy, P | 1 |
| Cho, J; Mullins, CD; Shaya, FT; Wong, W | 1 |
| Hedman, K; Larsson, LI | 1 |
| Larsson, LI; Mishima, HK; Orzalesi, N; Rossetti, L; Takamatsu, M | 1 |
| Camras, CB; Eisenberg, DL; Toris, CB | 1 |
| Aung, T; Chew, PT; Hung, PT | 1 |
| Bron, AM; Emmerich, KH | 1 |
| Diestelhorst, M; Nordmann, JP; Toris, CB | 1 |
| Bron, A | 1 |
| Bottoli, A; Fogagnolo, P; Fumagalli, E; Invernizzi, T; Orzalesi, N; Rossetti, I | 1 |
| Bernays, ME; Hampson, EC; Smith, RI | 1 |
| Honrubia, FM; Larsson, LI; Spiegel, D | 1 |
| Pfeiffer, N | 1 |
| Bojić, L; Mandić, Z; Novak-Laus, K; Sarić, D | 1 |
| Covert, DW; Halpern, MT; Robin, AL | 1 |
| Konstas, AG; Kozobolis, VP; Leech, J; Stewart, WC; Tersis, I | 1 |
| Birch, MK; Griffiths, PG; Johnson, ZK | 1 |
| Crick, MP; Etchells, DE; Morris, AH; Rossiter, JD | 1 |
| Chen, J; Fan, Z; Huang, Y; Li, D; Lin, H; Wang, N; Wu, H | 1 |
| Bottoli, A; Fogagnolo, P; Fumagalli, E; Orzalesi, N; Rossetti, L | 1 |
| Brignoli, R; Mermoud, A; Ravinet, E | 1 |
| Pajic, B | 1 |
| Day, D; Sharpe, ED; Stewart, JA; Stewart, WC | 1 |
| Culy, CR; Ibbotson, T; McGavin, JK; Perry, CM | 1 |
| Goto, Y; Ibaraki, N; Miyake, K | 1 |
| Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
| Houliara, D; Konstas, AG; Papapanos, P; Stewart, WC; Tersis, I | 1 |
| Agarwal, HC; Gulati, V; Pandey, RM; Saxena, R; Sihota, R | 1 |
| Arend, O; Harris, A; Remky, A; Wolter, P | 1 |
| Goto, Y; Ibaraki, N; Ishigaki, J; Miyake, K; Miyake, S; Oogiya, S; Ota, I | 1 |
| Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P | 1 |
| Bauer, P; Eichler, H; Findl, O; Groke, I; Schmetterer, L; Sycha, T; Vass, C | 1 |
| Baudouin, C; Blondin, C; Brignole, F; Debbasch, C; Hamard, P; Warnet, JM | 1 |
| Assalian, A; Castilloux, AM; Houde, M; LeLorier, J; Tingey, D | 1 |
| Alm, A; Gross, RL; Hedman, K | 1 |
| Camras, CB; Hedman, K | 1 |
| Amano, S; Inoue, K; Inoue, Y; Kato, S; Okugawa, K; Oshika, T; Tomita, G | 1 |
| Mozaffari, E; Reardon, G; Schwartz, GF | 1 |
| Kobayashi, H; Kobayashi, K; Okinami, S | 1 |
| Diestelhorst, M; Larsson, LI | 2 |
| Bojić, L; Karelović, D; Mandić, Z; Novak-Laus, K; Sonicki, Z | 1 |
| Agarwal, HC; Gulati, V; Saxena, R; Sihota, R | 1 |
| Adamsons, IA; Airaksinen, PJ; Fechtner, RD; Getson, AJ; Lines, CR | 1 |
| Diafas, S; Georgiadis, N; Karabatsas, CH; Konstas, AG; Kozobolis, VP; Mylopoulos, N; Papapanos, P; Stewart, WC | 1 |
| Carpenter, SP; DuBiner, HB; Khan, B; VanDenburgh, AM; Walters, TR | 1 |
| Aquino, MV; Aung, T; Chew, PT; Rojanapongpun, P | 1 |
| Feldman, RM; Sheu, WP; Shin, DH | 1 |
| Araie, M; Kitazawa, Y; Tomita, G; Tsukahara, S | 1 |
| Day, DG; Jenkins, JN; Sharpe, ED; Stewart, JA; Stewart, WC | 1 |
| Feldman, RM | 1 |
| Baudouin, C; Brignole, F; Creuzot-Garcher, C; Debbasch, C; Hamard, P; Pisella, PJ; Rat, P | 1 |
| Hirano, S; Nishida, T; Sagara, T; Seki, K; Suzuki, K | 1 |
| Akman, A; Akova, YA; Cetinkaya, A; Ertan, A | 1 |
| Cunliffe, I; García-Sánchez, J; Landry, J; Pajic, B; Rouland, JF; Spiegel, D; Traverso, C | 1 |
| Christodoulakis, E; Konstas, AG; Kozobolis, VP; Lallos, N; Stewart, JA; Stewart, WC | 1 |
| Sheu, WP; Susanna, R; Sussana, R | 1 |
| Bucci, MG; Centofanti, M; Manni, G; Oddone, F; Parravano, M | 1 |
| Călugăru, D; Călugăru, M | 5 |
| Fukuda, T; Nakamoto, K; Nanno, M; Yasuda, N | 1 |
| Kripke, DF; Liu, JH; Weinreb, RN | 1 |
| Beausencourt, E; Hamacher, T; Jütte, M; Lorger, C; Maier, H; Neff, HM; Schinzel, M; Schlaffer, G; Scholz, R; Schölzel-Klatt, A; Stewart, WC | 1 |
| Castillo, A; Fernandez-Vidal, A; Garcia-Feijoo, J; Garcia-Sanchez, J; Martinez-de-la-Casa, JM; Mendez-Hernandez, C | 1 |
| Hara, T; Hashimoto, T; Kubota, M; Kubota, S; Takahashi, Y; Tsuru, T | 1 |
| Althin, R; Dhawan, R; Sforzolini, BS; Zhou, Z | 1 |
| Bron, A; Elena, PP; Pouliquen, P; Rebica, H; Rouland, JF; Velasque, L | 1 |
| Downes, N; Olander, K; Schoenfelder, J; Zimmerman, TJ | 1 |
| Harris, A; Janulevicienë, I; Kagemann, L; McCranor, L; Siesky, B | 1 |
| Aung, T; Chan, YH; Chew, PT; Lim, MC; Rojanapongpun, P | 1 |
| Bastian, CD; Dietlein, TS; Jordan, JF; Krieglstein, GK | 1 |
| Bányai, L; Blask, KD; Konstas, AG; Kozobolis, VP; Maloutas, S; Stewart, WC; Teus, MA; Trüb, PR; Tsironi, S; Väth, J | 1 |
| Neufeld, AH | 1 |
| Bayer, A; Oeverhaus, U; Skrotzki, FE; Stewart, WC; Weiler, W | 1 |
| Aung, T; Chan, YH; Chew, PT | 1 |
| Burnier, MN; Saheb, NE; Saraiva, VS; Solari, HP; Ventura, MP; Vianna, RN | 1 |
| Hedman, K; Taube, A | 1 |
| Antinozzi, PP; Caccavale, A; Costagliola, C; Cotticelli, L; Parmeggiani, F; Sebastiani, A | 1 |
| Berkoff, DJ; Sanchez, LD | 1 |
| Adamsons, IA; Fechtner, RD; Lines, CR; McCarroll, KA | 1 |
| Boboridis, K; Jenkins, JN; Kallinderis, K; Konstas, AG; Stewart, WC; Tzetzi, D | 1 |
| Georgiadis, N; Karabatsas, CH; Koliakos, GG; Konstas, AG; Liakos, P; Ritch, R; Schlötzer-Schrehardt, U | 1 |
| Conde, A; Cruces, M; de la Torre, C; Flórez, A; García-Doval, I; González, B; Rosón, E | 1 |
| Ikeda, H; Mishima, HK; Mukai, S; Noma, H; Tsukamoto, H | 1 |
| Aagren, M; Buchholz, P; Holmstrom, S; Walt, J; Wickstrøm, J | 2 |
| Ishikawa, S; Nakamura, Y; Sakai, H; Sawaguchi, S; Shinjyo, S | 1 |
| Gillespie, BW; Musch, DC | 1 |
| Martínez, A; Sánchez, M | 4 |
| Antohi, I; Chiseliţă, D; Danielescu, C; Medvichi, R | 1 |
| Avila, MP; Magacho, L; Reis, R; Santos, LC; Shetty, RK | 1 |
| Goldberg, LD; Walt, J | 1 |
| Gehr, BT; Porzsolt, F; Weiss, C | 1 |
| Cunliffe, IA; Franks, WA; Renard, JP; Rojanapongpun, P | 1 |
| Murofushi, C; Namba, H; Namba, R | 1 |
| Carassa, R; Gandolfi, S; Manni, G; Marchini, G; Mastropasqua, L; Montanari, P; Orzalesi, N; Quaranta, L; Ratiglia, R; Rossetti, L; Traverso, C; Uva, M | 1 |
| Hirano, S; Liu, Y; Lu, Y; Nishida, T; Sagara, T; Yanai, R | 1 |
| Gandolfo, E; Gandolfo, F; Musig, A; Pizzolante, T; Quaranta, L; Rovida, F; Turano, R | 1 |
| Hong, S; Hong, YJ; Lee, CS; Seo, KY; Seong, GJ | 1 |
| Aston, SJ; Capel, B; Capell, BC; Chiu, ES; Jelks, EB; Jelks, GW; Press, R | 1 |
| Baudouin, C; Bron, AM; Creuzot-Garcher, C; Lizard, G; Malvitte, L; Montange, T; Vejux, A | 1 |
| Laengle, UW; Markstein, R; Pralet, D; Roman, D; Seewald, W | 1 |
| Covert, DW; Halpern, MT; Robin, AL; Schmier, JK | 1 |
| Soto, J | 2 |
| Hendrikse, F; Prins, MH; Schouten, JS; van der Valk, R; Webers, CA; Zeegers, MP | 1 |
| Chen, XM; Li, N; Wei, ML; Yao, X; Zhou, Y | 1 |
| Harris, A; Malinovsky, VE; McCranor, L; Rechtman, E; Siesky, B; Sines, D; Yung, CW; Zalish, M | 1 |
| Economou, AI; Jenkins, JN; Kaltsos, K; Konstas, AG; Lake, S; Stewart, WC | 1 |
| Oksüz, H; Tamer, C | 1 |
| Harasymowycz, P; Hutnik, CM; Nicolela, M; Stewart, WC | 1 |
| Kiuchi, T; Motoyama, Y; Oshika, T | 1 |
| Ari, S; Caça, I; Keklikçi, U; Simsek, H; Unlü, K | 1 |
| Salmon, JF; Sharma, T | 1 |
| Boehm, A; Centofanti, M; Goldblum, D; Karabatsas, CH; Rossetti, L; Topouzis, F; Vetrugno, M; Viswanathan, A; Vorwerk, C | 1 |
| Mychaskiw, MA; Stewart, JA; Stewart, WC | 1 |
| Campa, C; Costagliola, C; Incorvaia, C; Lamberti, G; Parmeggiani, F; Perri, P; Sebastiani, A; Virgili, G | 1 |
| Küsbeci, T; Oztürk, F; Yavas, GF | 1 |
| de Vogel, SC; Hendrikse, F; Prins, MH; Schouten, JS; van der Valk, R; Webers, CA | 1 |
| Konstas, AG; Kruft, B; Nelson, LA; Stewart, WC | 1 |
| Efremova, R; Konstas, AG; Kozobolis, VP; Makridaki, I; Stewart, WC; Tsironi, S | 1 |
| Avni, I; Barak, A; Ben-Shoshan, J; George, J; Levkovitch-Verbin, H; Luboshits, G; Rosner, M; Schwartz, S; Ziv, H | 1 |
| Agarwal, R; Agrawal, SS; Galpalli, ND; Gupta, SK; Saxena, R; Srivastava, S | 1 |
| Cvenkel, B; Nelson, LA; Stewart, JA; Stewart, WC | 1 |
| Buchholz, P; Ferreras, A; Friis, MM; Gouws, P; Hommer, A; Steeds, C; Thygesen, J; Wickstrøm, J | 1 |
| Attarzade, H; Eslami, F; Moeini, H; Naderibeni, A; Rismanchian, A | 1 |
| Bartlett, JD; Evans, DW; Houde, B; Shaikh, A; Than, TP | 1 |
| Bastien, NR; Koulis, T; Lesk, MR; Sampalis, F; Sampalis, JS | 1 |
| Fuchsjäger-Mayrl, G; Garhofer, G; Hommer, A; Resch, H; Schmetterer, L; Vass, C | 1 |
| Floriani, I; Konstas, AG; Miglior, S; Pizzolante, T; Quaranta, L | 1 |
| Beckers, HJ; Hendrikse, F; Schouten, JS; van der Valk, R; Webers, CA | 1 |
| Nelson, LA; Sharpe, ED; Stewart, JA; Stewart, WC; Williams, RD | 1 |
| Dimopoulos, AT; Konstas, AG; Mikropoulos, D; Moumtzis, G; Nelson, LA; Stewart, WC | 1 |
| Hunter, A; Liu, W; Ma, J; Zhang, W | 1 |
| Ho, WO; Jaberoo, D; Lazaridou, MN; Montgomery, DM | 1 |
| Czechowicz-Janicka, K; Kałuzny, BJ; Kałuzny, J; Kecik, D; Sobecki, R; Stewart, JA; Stewart, WC | 1 |
| Skorkovská, K | 1 |
| Martínez, A; Slof, J | 1 |
| Böhm, AG; Lampel, J; Pillunat, LE; Rummelt, C; Schlötzer-Schrehardt, U; Schmidt, E; Terai, N | 1 |
| Berdeaux, G; Denis, P; Jeanbat, V; Lafuma, A; Laurendeau, C | 1 |
| Onaran, Z; Ornek, K; Turgut, Y | 1 |
| Ikeda, T; Ishida, O; Kojima, S; Sugiyama, T | 1 |
| Berdeaux, G; De Natale, R; Lafuma, A | 1 |
| Liu, JH; Medeiros, FA; Slight, JR; Weinreb, RN | 1 |
| Balestrazzi, A; Frezzotti, P; Malandrini, A; Martone, G; Mittica, V; Motolese, E; Motolese, I; Motolese, PA; Pichierri, P; Tosi, GM; Traversi, C | 1 |
| Chalkidou, S; Georgopoulos, G; Halkiadakis, I; Kostakou, A; Markomichelakis, NN; Papakonstantinou, D | 1 |
| Curran, MP; Orman, JS | 1 |
| Cai, JP; Cheng, JW; Li, Y; Wei, RL; Xi, GL | 1 |
| Longo, A; Reibaldi, M; Uva, MG | 1 |
| Anderson, L; Goverdhan, S; Kirwan, JF; Lockwood, AJ; Wormald, R | 1 |
| Delgado-Ortega, L; Díaz-Cerezo, S; Pinazo-Durán, MD; Soto-Alvarez, J; Vinuesa-Silva, I; Vinuesa-Silva, JM | 1 |
| Konstas, AG; Kozobolis, VP; Lasaridis, AN; Mikropoulos, D; Nelson, LA; Pikilidou, MI; Sarafidis, PA; Stewart, WC; Tsironi, S | 1 |
| Bean, GW; Grunden, JW; Hwang, LJ; Sultan, MB; Varma, R | 1 |
| Cai, JP; Cheng, JW; Wei, RL | 1 |
| Abuin, A; Eberhart, DE; Gerhardt, B; Harrison, B; Mixon, T; Rice, DS; Whitlock, NA; Wilson, A; Yu, XQ | 1 |
| Cheng, JW; Li, Y; Wei, RL | 1 |
| Bulcun, E; Ekici, A; Ekici, M; Ergin, A; Güllü, R; Ornek, K | 1 |
| Jamshidian-Tehrani, M; Mehdizadeh, M; Nowroozzadeh, MH | 1 |
| Laxmana Rao, HB; Sekhar, GC | 1 |
| Bellini, R; Bracchino, M; Bucarelli, M; Caravati, C; Celesia, L; Cerqueti, P; Clemente, A; Franchin, S; Pasinetti, GM; Rossi, GC; Tinelli, C | 1 |
| Jay Katz, L; Myers, JS | 1 |
| Asouhidou, I; Chatzibalis, T; Karabatakis, V; Natsis, K; Nousios, G; Vlasis, K | 1 |
| Bean, GW; Grunden, JW; Hwang, LJ; Varma, R | 1 |
| Díaz, F; García-Campos, J; Moreno, M; Pérez de Vargas, I; Vidal, L; Villena, A | 1 |
| de Moraes, CG; Facio, AC; Hatanaka, M; Reis, AS; Susanna, R; Suzuki, R; Vidal, KS | 1 |
| Grunden, JW; Kwok, K; Miglior, S | 1 |
| Dariel, R; Fénolland, JR; Giraud, JM; Hamam, O; Maÿ, F; Renard, JP; Sadat, AM | 1 |
| Ayyala, RS; Blake, RC; Ross, A | 1 |
| Chalfin, S; Crane, C; D'Andrea, J; Garay, R; Hatcher, D; Lu, ST; Marchello, D; Ziriax, J | 1 |
| Grunden, JW; Higginbotham, EJ; Kim, EE; Kwok, KK; Olander, KW; Tressler, CS | 1 |
| Camras, CB; Fan, S; Johnson, TV; Toris, CB; Zhan, G | 1 |
| Campos, JG; Díaz, F; Moreno, M; Pérez de Vargas, I; Vidal, L; Villena, A | 1 |
| Baudouin, C; Bron, A; Denis, P; Nordmann, JP; Renard, JP; Rouland, JF; Sellem, E | 1 |
| Adams, BH; Broderick, DF; Menke, DM; Runyan, BR; Shetty, RK; Tun, HW | 1 |
| Nowroozzadeh, MH | 1 |
| Cavallotti, C; Feher, J; Librando, A; Pacella, E; Pacella, F; Pecori-Giraldi, J | 1 |
| Dimopoulos, AT; Embeslidis, TA; Haidich, AB; Konstas, AG; Mikropoulos, DG; Papanastasiou, A; Stewart, WC | 1 |
| Häfliger, IO; Pajic, B; Pajic-Eggspuehler, B | 1 |
| Boehm, A; Centofanti, M; Gandolfi, S; Haustein, M; Hommer, A; Manni, G; Oddone, F; Rossetti, L; Sangermani, C; Sportelli, V; Tanga, L | 1 |
| Hendrikse, F; Peeters, A; Prins, MH; Schouten, JS; Severens, JL; Webers, CA | 1 |
| Felchle, LM; Miller, PE; Smith, LN | 1 |
| Guzy, C; Heckmann, B; Miller, PJ; Schwenn, O | 1 |
| Bastien, NR; Behki, R; Boucher, S; Crichton, AC; Harasymowycz, P; Hutnik, CM; Ibrahim, F; Liao, C; Rifkind, AW; Sampalis, JS; Solomon, L | 1 |
| Della Paolera, M; Giampani, J; Lottenberg, CL; Mendonça, M; Paranhos, A; Russ, H; Silva, MJ; Torres, RJ | 1 |
| Aydin, N; Erbil, HH; Mesci, C | 1 |
| Bean, GW; Hwang, LJ; Sultan, MB; Trocme, S | 1 |
| Sihota, R | 1 |
| Hendrikse, F; Peeters, A; Prins, MH; Schouten, JS; Webers, CA | 1 |
| Baudouin, C; Brignole-Baudouin, F; Liang, H; Nakib, Z; Riancho, L | 1 |
| Baudouin, C; Brignole-Baudouin, F; Liang, H; Pauly, A; Riancho, L | 1 |
| Dombi, TM; Huang, K; Jessen, B; Kwok, KK; Tressler, CS; Wirostko, BM; Wiseman, RL | 1 |
| Petrović, MJ; Petrović, N; Srećković, S; Vukosavljević, M | 1 |
| Ito, Y; Murao, T; Nagai, N; Oe, K; Okamoto, N; Shimomura, Y | 1 |
| Liu, JH; Realini, T; Weinreb, RN | 1 |
| Chi-Burris, K; Freedman, SF; Khaw, PT; Maeda-Chubachi, T; Simons, BD; Wirostko, B; Yan, E | 1 |
| Pachimkul, P; Thoophom, P; Yuttitham, K | 1 |
| Ammar, DA; Kahook, MY | 1 |
| Babić, N; Camara, C; Cieślińska, I; Ferkova, S; Holló, G; Januleviciene, I; Kaluzny, BJ; Kóthy, P; Kozobolis, V; Kristoffersen, MS; Krzyzanowska-Berkowska, P; Mikropoulos, DG; Misiuk-Hojlo, M; Nelson, LA; Quaranta, L; Russo, A; Stewart, JA; Stewart, WC; Teus, MA; Thelen, U | 1 |
| Ge, J; Li, XX; Li, YM; Sheng, YH; Sun, NX; Sun, XH; Yao, K; Zhao, JL; Zhong, Z | 1 |
| Higa, R; Inoue, K; Okayama, R; Sawada, H; Tomita, G; Wakakura, M | 1 |
| Ammar, DA; Fechtner, RD; Kahook, MY; Katz, LJ; Noecker, RJ | 1 |
| Kobayashi, H | 2 |
| Beckers, HJ; Hendrikse, F; Jansonius, NM; Schouten, JS; Severens, JL; van Gestel, A; Webers, CA | 1 |
| Altan, C; Eren, MH; Gungel, H; Pasaoglu, IB; Sabanci, S | 1 |
| Fan, S; Gangahar, C; Gulati, V; Maslonka, MA; Toris, CB; Zhao, M | 1 |
| Cojocaru, I; Pop, A; Stefan, C | 1 |
| Cottingham, AJ; Hollander, DA; Katz, LJ; Rauchman, SH; Schiffman, RM; Simmons, ST; Williams, JM | 1 |
| Congdon, NG; Friedman, DS; Gilbert, D; Goggins, W; Kader, MA; Krishnadas, R; Quigley, HA; Ramakrishnan, R; Tielsch, J | 1 |
| Kashiwagi, K | 1 |
| Chen, DF; Chen, H; Cho, KS; Guo, W; Luo, G; Pang, IH; Wang, WH; Yang, Q; Yu, D | 1 |
| Ge, J; Sun, X; Wang, N; Zhao, J | 1 |
| Zeldovich, A | 1 |
| Garhöfer, G; Hommer, A; Popa-Cherecheanu, A; Qiao, C; Resch, H; Schmetterer, L; Sperl, P | 1 |
| Oláh, Z; Veselovský, J | 3 |
| Alliot, E; Baudouin, C; Delval, L; Gabisson, P; Vincent, B | 1 |
| Balbaba, M; Çelebi, S; Ulaş, F | 1 |
| Dimopoulos, AT; Empeslidis, T; Haidich, AB; Holló, G; Konstas, AG; Mikropoulos, DG; Ritch, R; Teus, MA | 1 |
| Hong, SJ; Lai, YH; Wu, KY; Wu, PC | 1 |
| Irkec, M; Katsanos, A; Konstas, AG; Mocan, MC; Voudouragkaki, IC | 1 |
| Enoki, T; Hirota, N; Kanda, T; Kojima, T; Mizukawa, A; Sato, H; Shoji, T; Takeuchi, M | 1 |
| Fazil, K; Gocmez, E; Gulkilik, G; Kandemir, N; Kocabora, MS; Ozsutcu, M | 1 |
| Nixon, DR | 1 |
| Apostolopoulos, M; Georgalas, I; Koutsandrea, C; Papaconstantinou, D; Tsikripis, P | 1 |
| Barros, Jde N; Faria, NV; Gomes, JÁ; Mello, PA; Montiani-Ferreira, F; Nogueira-Filho, PA; Russ, HH | 1 |
| He, M; Huang, W; Wang, W | 1 |
| Choi, CY; Kim, CY; Kim, JM; Shim, SH | 1 |
| Cheng, JW; Ge, YR; Lou, H; Wei, RL; Zong, Y | 1 |
| Chen, R; Deng, QJ; Li, SM; Li, Y; Ong, ML; Yang, ZR; Zhan, SY; Zhong, Z | 1 |
| Marques, A | 1 |
| Ando, T; Hamada, R; Hamasaki, Y; Hataya, H; Honda, M; Ishikura, K; Kawaguchi, E; Miura, M; Morikawa, Y; Nagaoka, Y; Noda, E; Sakai, T | 1 |
| Agnifili, L; Di Staso, S; Fasanella, V; Lanzini, M; Mastropasqua, L; Mastropasqua, R; Pedrotti, E | 1 |
| Akhtar, M; Alaei, M; Kausar, H; Najmi, AK | 1 |
| Boboridis, KG; Dragoumis, ND; Giannopoulos, T; Haidich, AB; Kahook, MY; Konstas, AG; Makridis, AK; Paschalinou, E; Voudouragkaki, IC | 1 |
| Bautista, D; Chew, PT; Khoo, AL; Lim, BP; Lin, L; Sng, CC; Teng, M; Wong, HT; Wu, TS; Yip, LW; Zhao, YJ | 1 |
| Özyol, E; Özyol, P | 1 |
| Kumar, MS; Mishra, D; Sinha, BP | 1 |
| Agarwal, P; Agarwal, R; Ismail, NM; Kannan Kutty, M; Kapitonova, MY; Razali, N; Salmah Bakar, N; Smirnov, A | 1 |
| Boehm, A; Centofanti, M; Fogagnolo, P; Goldblum, D; Karabatsas, CH; Rossetti, L; Sacchi, M; Topouzis, F; Vetrugno, M; Vorwerk, C | 1 |
| Cheng, JW; Lou, H; Wang, H; Wei, RL; Zong, Y | 1 |
| Abe, H; Araie, M; Inoue, T; Kuwayama, Y; Suganami, H; Tanihara, H; Yamamoto, T | 1 |
| Lee, NY; Park, CK; Park, HY | 1 |
| Kanda, T; Mine, I; Sakurai, Y; Shibata, M; Taguchi, M; Takeuchi, M | 1 |
| Colombo, L; De Cillà, S; Fogagnolo, P; Montesano, G; Orzalesi, N; Rossetti, L | 1 |
| Fuma, S; Hara, H; Imamura, T; Kanno, Y; Shimazawa, M; Takano, N; Tsuruma, K | 1 |
| Bachiller Cacho, MP; de Frutos-Lezaun, M; Egía Zurutuza, A; Irastorza Larburu, MB; Martínez-Soroa, I; Ostra Beldarrain, M | 1 |
| Fukuda, M; Sasaki, H; Shibata, N; Shibata, S; Shibata, T; Sugiyama, K; Takeda, N | 1 |
| Akaishi, T; Fuwa, M; Kawazu, K; Kirihara, T; Mano, H; Shimazaki, A; Ueda, K; Yamashita, N | 1 |
| Boboridis, KG; Haidich, AB; Kapis, P; Katsanos, A; Konstas, AG; Marinopoulos, K; Mikropoulos, DG; Pagkalidou, E; Panayiotou, D; Quaranta, L; Voudouragkaki, IC | 1 |
| Armour, MD; Dees, DD; Greller, A; Madsen, R; Paglia, D; Spahn, KJ; Wagner, LS | 1 |
| Selen, F; Tekeli, O; Yanık, Ö | 1 |
| Ates, H; Degirmenci, C; Guven Yilmaz, S; Karakoyun, YE; Yusifov, E | 1 |
| Holopainen, JM; Pisella, PJ; Rantamäki, AH; Robciuc, A; Ruokonen, SK; Wiedmer, SK; Witos, J | 1 |
| Bahler, CK; Bertrand, JA; Dosa, PI; Fautsch, MP; Holman, BH; Millar, JC; Overby, DR; Rinkoski, TA; Roy Chowdhury, U; Sherwood, JM; Stoltz, KL | 1 |
| Belcaro, G; Feragalli, B; Gizzi, C; Hosoi, M; Hu, S; Torino-Rodriguez, P | 1 |
| Agnifili, L; Brescia, L; Fasanella, V; Mastropasqua, L; Mastropasqua, R; Oddone, F; Scatena, B | 1 |
| Carleton, B; Etminan, M; Mikelberg, FS; Wendel, C; Zakrzewski, H | 1 |
| Hashimoto, M; Hizaki, H; Kuwayama, Y; Otsuka, N; Suzuki, K | 1 |
| Arciniegas-Perasso, CA; Clemente-Tomás, R; Duch-Samper, AM; García-Ibor, F; Hervás-Hernandis, JM; Ruiz-Del Río, N | 1 |
| Almobarak, F; Edward, DP; Rahmathullah, R; Robin, AL; Stagg, BC; Stein, JD; Zhao, PY | 1 |
| Samuelson, TW | 1 |
| Ibrahim, DG; Iwata, W; Kiuchi, Y; Ko, JA; Okumichi, H | 1 |
| Brown, GC; Brown, MM | 1 |
| Akaishi, T; Fuwa, M; Kato, M; Mieda, M; Shimazaki, A; Taniguchi, T; Yamashita, N | 1 |
| Bu, R; Feng, S; Ge, Y; Gou, J; He, H; Tang, X; Wang, J; Xu, J; Yin, T; Zhang, A; Zhang, Y | 1 |
| Aptel, F; Astakhov, YS; Clarke, J; Coupier, L; Csutak, A; Jugaste, T; Lavín-Dapena, C; Moreno-Montañés, J; Nordmann, JP; Pfeiffer, N; Schmickler, S; Stalmans, I; Volksone, L; Żarnowski, T | 1 |
| Ha, A; Jeoung, JW; Kim, YK; Park, KH; Wy, S | 1 |
| Huang, S; Xing, Y; Zhang, K; Zhu, L | 1 |
| Esfandiari, H; Tanna, AP; Teramoto, K | 1 |
| Gao, S; Guo, Y; Li, S; Tang, Y; Zhang, X | 1 |
| Liao, Y; Nie, X; Wang, Y | 1 |
| Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C | 1 |
| Armengol, L; Banchs, I; Canut, MI; Casaroli-Marano, RP; González, JR; Kudsieh, B; Mattlin, H; Villa, O | 1 |
| Akaray, İ; Çınar, AC; Çınar, AK; Güçlü, H; Gürlü, V; Sakallıoğlu, AK; Şambel Aykutlu, M | 1 |
| Aihara, M; Kishimoto, N; Kizaki, J; Saito, Y; Shibasaki, Y; Wada, Y | 1 |
| Coroneo, M; Huang, J; Kalloniatis, M; Tong, J; Zangerl, B | 1 |
| Fan, S; Gilbert, J; Gulati, V; Kazemi, A; Kolli, A; Moroi, SE; Musch, DC; Reed, DM; Sit, AJ; Toris, CB | 1 |
| Fassari, C; Holló, G; Kirwan, J; Lopez-Lopez, F; Oddone, F; Zimina, M | 1 |
| Karlova, EV; Zolotarev, AV | 1 |
| Ahn, HS; Chang, DJ; Chang, J; Kang, HY; Lee, H; Lee, JW; Suh, JK | 1 |
| Alekseev, IB; Alekseeva, LI; Volkova, AV | 1 |
| Gou, J; He, H; Long, L; Ning, Y; Tang, X; Wang, Z; Xiong, J; Yin, T; Zhang, Y; Zhao, J | 1 |
| Achiron, A; Goldberg, M; Hayat, H; Masarwa, D | 1 |
| Gugleta, K; Hasler, PW; Saruhan, Y | 1 |
| Hirooka, K; Kiuchi, Y; Ko, JA; Komatsu, K; Kondo, S; Minamoto, A; Okumichi, H | 1 |
| Chang, RT; Chaya, C; De Francesco, T; Gallardo, M; Gazzard, G; Gulati, S; Huang, MJ; Levin, A; Liu, WW; Porter, M; Samuelson, TW; Shah, M; Sieck, E | 1 |
55 review(s) available for timolol and latanoprost
| Article | Year |
|---|---|
Will latanoprost be the 'wonder' drug of the '90s for the treatment of glaucoma?
Topics: Clinical Trials as Topic; Glaucoma, Open-Angle; Humans; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 1996 |
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 1997 |
Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Circadian Rhythm; Dose-Response Relationship, Drug; Eye; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 1997 |
The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
Topics: Acetazolamide; Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 1997 |
Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States.
Topics: Adrenergic beta-Antagonists; Clinical Trials, Phase III as Topic; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Scandinavian and Nordic Countries; Timolol; United Kingdom; United States | 1997 |
Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Aqueous Humor; Brimonidine Tartrate; Clonidine; Drug Synergism; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 1999 |
Bimatoprost: a member of a new class of agents, the prostamides, for glaucoma management.
Topics: Amides; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Timolol | 2001 |
Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris Diseases; Latanoprost; Male; Middle Aged; Ocular Hypertension; Pigmentation Disorders; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Risk Factors; Single-Blind Method; Timolol; Treatment Outcome | 2001 |
Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Topics: Administration, Topical; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Conjunctival Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glaucoma, Open-Angle; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2002 |
The effect of latanoprost on circadian intraocular pressure.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol | 2002 |
Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2002 |
Latanoprost versus combined timolol and dorzolamide.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Synergism; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2002 |
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Muscarinic Agonists; Ocular Hypertension; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 2002 |
[Comparison of latanoprost monotherapy with timolol-dorzolamide combination in patients with open-angle glaucoma or ocular hypertension].
Topics: Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2002 |
Four years later: a clinical update on latanoprost.
Topics: Antihypertensive Agents; Aqueous Humor; Blood Flow Velocity; Circadian Rhythm; Clinical Trials as Topic; Drug Therapy, Combination; Eye; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Safety; Sulfonamides; Thiophenes; Timolol | 2003 |
Latanoprost : an update of its use in glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Combinations; Eye Diseases; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2003 |
Interventions for normal tension glaucoma.
Topics: Antihypertensive Agents; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol; Vincamine | 2003 |
Pooled-data analysis of three randomized, double-masked, six-month studies comparing intraocular pressure-reducing effects of latanoprost and timolol in patients with ocular hypertension.
Topics: Antihypertensive Agents; Double-Blind Method; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Retrospective Studies; Timolol; Treatment Outcome | 2003 |
An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol | 2004 |
[Timolol topical ophthalmic combination].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2004 |
[Latanoprost topical ophthalmic combinations].
Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Amides; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2005 |
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome; United States | 2006 |
The fading of reported effectiveness. A meta-analysis of randomised controlled trials.
Topics: Adrenergic beta-Antagonists; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Cholesterol, LDL; Drug Evaluation; Heptanoic Acids; Humans; Intraocular Pressure; Latanoprost; Pravastatin; Prostaglandins F, Synthetic; Publication Bias; Pyrroles; Randomized Controlled Trials as Topic; Sample Size; Selection Bias; Time Factors; Timolol; Treatment Outcome | 2006 |
Successful management of orbital cellulitis and temporary visual loss after blepharoplasty.
Topics: Abscess; Adult; Anti-Bacterial Agents; Blepharoplasty; Blindness; Brimonidine Tartrate; Cavernous Sinus Thrombosis; Cellulitis; Clindamycin; Combined Modality Therapy; Decompression, Surgical; Dexamethasone; Drainage; Emergencies; Exophthalmos; Female; Gentamicins; Humans; Latanoprost; Nerve Compression Syndromes; Occupational Exposure; Optic Nerve Diseases; Orbital Diseases; Penicillins; Prostaglandins F, Synthetic; Quinoxalines; Streptococcal Infections; Streptococcus pyogenes; Surgical Wound Infection; Teaching; Timolol; Vancomycin; Vision Disorders | 2006 |
Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.
Topics: Antihypertensive Agents; Databases, Factual; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol | 2007 |
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Dinoprost; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2006 |
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.
Topics: Antihypertensive Agents; Cost-Benefit Analysis; Glaucoma, Open-Angle; Humans; Latanoprost; Markov Chains; Prostaglandins F, Synthetic; Quality-Adjusted Life Years; Timolol | 2009 |
Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2008 |
[Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Drug Combinations; Glaucoma; Humans; Latanoprost; Middle Aged; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
[Fixed combinations of glaucoma medications].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2008 |
Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Clinical Trials as Topic; Cloprostenol; Cost-Benefit Analysis; Drug Combinations; Glaucoma; Humans; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2009 |
Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized, controlled trials.
Topics: Antihypertensive Agents; Drug Combinations; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol | 2009 |
[Development of conjunctival hyperemia with the use of a fixed combination of latanoprost/timolol: systematic review and meta-analysis of clinical trials].
Topics: Aged; Brimonidine Tartrate; Clinical Trials as Topic; Cloprostenol; Conjunctival Diseases; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Hyperemia; Latanoprost; Middle Aged; Ocular Hypertension; Odds Ratio; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Timolol; Travoprost | 2009 |
Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
Topics: Antihypertensive Agents; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Risk Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2009 |
Meta-analysis of medical intervention for normal tension glaucoma.
Topics: Aged; Amides; Antihypertensive Agents; Betaxolol; Bimatoprost; Brimonidine Tartrate; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Quinoxalines; Randomized Controlled Trials as Topic; Sulfonamides; Thiazines; Thiophenes; Timolol; Tonometry, Ocular; Travoprost | 2009 |
Systematic review of intraocular pressure-lowering effects of adjunctive medications added to latanoprost.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Databases, Factual; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Optic Nerve Diseases; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol | 2009 |
[Bimatoprost therapy in glaucoma].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Evidence-Based Medicine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Treatment Outcome | 2009 |
The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials.
Topics: Benzalkonium Compounds; Humans; Keratitis; Latanoprost; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol | 2010 |
An Indian perspective on primary angle closure and glaucoma.
Topics: Acute Disease; Anterior Chamber; Antihypertensive Agents; Chronic Disease; Cornea; Disease Progression; Drug Administration Schedule; Glaucoma, Angle-Closure; Humans; Incidence; India; Iris; Latanoprost; Ocular Hypertension; Ophthalmologic Surgical Procedures; Prevalence; Prostaglandins F, Synthetic; Timolol | 2011 |
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Child; Child, Preschool; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Eye Neoplasms; Female; Humans; Latanoprost; Male; Melanoma; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Skin Neoplasms; Timolol; Young Adult | 2011 |
[The latest developments in glaucoma therapy using fixed combination products].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate, Timolol Maleate Drug Combination; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2011 |
[Fixed combination of topical prostaglandin analogue in glaucoma treatment].
Topics: Amides; Antihypertensive Agents; Bimatoprost; Carbonic Anhydrase Inhibitors; Cloprostenol; Drug Combinations; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Optic Nerve; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Sulfonamides; Thiazines; Timolol; Travoprost; Treatment Outcome; Visual Fields | 2011 |
Latanoprost/timolol fixed combination for the treatment of glaucoma.
Topics: Animals; Antihypertensive Agents; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2013 |
Efficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Drug Tolerance; Female; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Sulfonamides; Thiophenes; Timolol | 2013 |
Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma.
Topics: Antihypertensive Agents; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome | 2014 |
Meta-analysis of randomized controlled trials comparing latanoprost with timolol in the treatment of Asian populations with chronic angle-closure glaucoma.
Topics: Asia; Glaucoma, Angle-Closure; Humans; Latanoprost; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Safety; Timolol | 2014 |
Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost | 2014 |
Efficacy and tolerability of prostaglandin-timolol fixed combinations: an updated systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Timolol; Travoprost | 2015 |
The efficacy of the fixed combination of latanoprost and timolol versus other fixed combinations for primary open-angle glaucoma and ocular hypertension: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bimatoprost; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2020 |
Intractable Ocular Diseases and Treatment Progress.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Cataract; Diabetic Retinopathy; Drug Delivery Systems; Dry Eye Syndromes; Eye Diseases; Glaucoma; Humans; Latanoprost; Macular Degeneration; Photosensitizing Agents; Timolol; Treatment Outcome; Verteporfin | 2020 |
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost | 2022 |
Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis.
Topics: Antihypertensive Agents; Benzoates; beta-Alanine; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; rho-Associated Kinases; Timolol; Treatment Outcome | 2022 |
[Xalacom: possibilities and advantages of the drug in the treatment of patients with glaucoma].
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quality of Life; Timolol; Treatment Outcome | 2022 |
[ROCK (RHO-KINASE INHIBITORS) FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION].
Topics: Antihypertensive Agents; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; rho-Associated Kinases; Timolol; Treatment Outcome; United States | 2023 |
185 trial(s) available for timolol and latanoprost
| Article | Year |
|---|---|
Comparative phase III clinical trial of latanoprost and timolol in patients with elevated intraocular pressure.
Topics: Circadian Rhythm; Double-Blind Method; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 1995 |
Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Conjunctiva; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 1994 |
Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exfoliation Syndrome; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Time Factors; Timolol | 1995 |
Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Chronic Disease; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Posture; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular | 1996 |
A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Iris Diseases; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic; Timolol; Visual Acuity | 1996 |
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Conjunctiva; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Hyperemia; Intraocular Pressure; Iris Diseases; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic; Timolol; United States | 1996 |
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Conjunctiva; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 1996 |
A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Scandinavian and Nordic Countries; Timolol | 1996 |
Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Exfoliation Syndrome; Eye Color; Female; Glaucoma, Open-Angle; Hemodynamics; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Timolol; Visual Acuity; Visual Fields | 1996 |
A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Blood Flow Velocity; Ciliary Body; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Ophthalmic Solutions; Orbit; Prospective Studies; Prostaglandins F, Synthetic; Regional Blood Flow; Retinal Artery; Timolol; Ultrasonography, Doppler, Color | 1996 |
The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aqueous Humor; Blood-Aqueous Barrier; Cross-Over Studies; Double-Blind Method; Eye Proteins; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 1997 |
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 1995 |
The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
Topics: Adrenergic beta-Antagonists; Double-Blind Method; Europe; Eye Color; Glaucoma; Humans; Incidence; Intraocular Pressure; Iris; Iris Diseases; Latanoprost; Melanins; Melanosis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Time Factors; Timolol; United States | 1997 |
Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prostaglandins F, Synthetic; Safety; Timolol; United Kingdom | 1998 |
Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular | 1998 |
Comparison of two fixed combinations of latanoprost and timolol in open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 1998 |
Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Eye Color; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Timolol | 1998 |
Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.
Topics: Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Germany; Glaucoma, Open-Angle; Humans; Insurance, Health, Reimbursement; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 1998 |
Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow.
Topics: Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Choroid; Chronic Disease; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Treatment Outcome | 1998 |
A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Topics: Administration, Topical; Adult; Aqueous Humor; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Iris Diseases; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pigmentation Disorders; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 1999 |
Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Circadian Rhythm; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Treatment Outcome | 1999 |
Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Clonidine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fluorophotometry; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 1999 |
Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Circadian Rhythm; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular | 1999 |
Daily cost of newer glaucoma agents.
Topics: Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Gels; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Solutions; Sulfonamides; Thiophenes; Timolol | 1999 |
Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Safety; Timolol; Treatment Outcome | 1999 |
Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanopr
Topics: Adult; Aged; Antihypertensive Agents; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 2000 |
Comparison of latanoprost monotherapy to dorzolamide combined with timolol in patients with glaucoma and ocular hypertension.A 3-month randomised study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Circadian Rhythm; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2000 |
Latanoprost versus timolol gel to prevent ocular hypertension after phacoemulsification and intraocular lens implantation.
Topics: Adrenergic beta-Antagonists; Aged; Anterior Chamber; Antihypertensive Agents; Cell Count; Double-Blind Method; Female; Gels; Humans; Intraocular Pressure; Latanoprost; Lens Implantation, Intraocular; Male; Ocular Hypertension; Phacoemulsification; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2000 |
Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Conjunctiva; Cornea; Double-Blind Method; Female; Fluorescent Dyes; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Rose Bengal; Tears; Timolol; Treatment Outcome | 2000 |
Latanoprost: experience of 2-year treatment in Scandinavia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Scandinavian and Nordic Countries; Timolol; Treatment Outcome | 2000 |
Additive effect of latanoprost to the combination of timolol and dorzolamide.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2000 |
Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2000 |
The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension. a 6-month, randomized, multicenter study. German Latanoprost Study Group.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2000 |
Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2000 |
Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Gels; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Pulsatile Flow; Sclera; Timolol; Tonometry, Ocular; Venous Pressure | 2000 |
Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol: A double-masked, randomized, one-year study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cell Count; Double-Blind Method; Drug Therapy, Combination; Endothelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2001 |
Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2001 |
Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2000 |
The role of the uveoscleral outflow in the management of pigmentary glaucoma: a 24-month study comparing latanoprost with timolol.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aqueous Humor; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Sclera; Timolol; Uvea | 2000 |
The effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2001 |
Effect on intraocular pressure during 24 hours after repeated administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in patients with ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2001 |
Intraindividual comparison of the effects of a fixed dorzolamide-timolol combination and latanoprost on intraocular pressure after small incision cataract surgery.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Lens Implantation, Intraocular; Male; Middle Aged; Minimally Invasive Surgical Procedures; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2001 |
Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2001 |
Intraocular pressure over 24 hours after repeated administration of latanoprost 0.005% or timolol gel-forming solution 0.5% in patients with ocular hypertension.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Female; Gels; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2001 |
Comparison of the additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized, open-label, multicenter study in Greece.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Greece; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2001 |
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Pigmentation Disorders; Prodrugs; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost; Treatment Outcome | 2001 |
Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis.
Topics: Administration, Topical; Aged; Antihypertensive Agents; Benzalkonium Compounds; Conjunctiva; Conjunctivitis, Allergic; Cross-Over Studies; Eosinophils; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Leukocyte Count; Lymphocytes; Male; Middle Aged; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Tears; Timolol | 2001 |
[A comparison between latanoprost and timolol in treatment of patients with primary open-angle glaucoma and ocular hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2000 |
[Study on hypotensive effect of latanoprost vs timolol-dorzolamide association].
Topics: Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma; Humans; Latanoprost; Male; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2002 |
A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.
Topics: Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Greece; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2002 |
Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Safety; Timolol; Treatment Outcome | 2002 |
Does glaucoma medication influence the diameter of the retinal arteriole in the human eye? (A pilot study using the retinal vessel analyser).
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Arterioles; Betaxolol; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Glaucoma; Humans; Latanoprost; Middle Aged; Ophthalmology; Pilot Projects; Prostaglandins F, Synthetic; Quinoxalines; Retinal Artery; Sulfonamides; Thiazines; Timolol | 2001 |
The effect of latanoprost compared with timolol in African-American, Asian, Caucasian, and Mexican open-angle glaucoma or ocular hypertensive patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Asia; Black People; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Mexico; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; White People | 2002 |
Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Safety; Timolol | 2002 |
Comparison of latanoprost, brimonidine and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2002 |
A comparison of the effects on intraocular pressure of latanoprost 0.005% and the fixed combination of dorzolamide 2% and timolol 0.5% in patients with open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2002 |
A comparison of the fixed combination of latanoprost and timolol with its individual components.
Topics: Aged; Circadian Rhythm; Double-Blind Method; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2002 |
Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.
Topics: Aged; Antihypertensive Agents; Black People; Cloprostenol; Disease Progression; Double-Blind Method; Drug Costs; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Travoprost; United States; Vision Disorders; Visual Fields | 2002 |
The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Patient Satisfaction; Prostaglandins F, Synthetic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol | 2003 |
The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cross-Over Studies; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2003 |
Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Safety; Timolol | 2003 |
Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
Topics: Adult; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Safety; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2003 |
Peak pressures: crossover study of timolol and latanoprost.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Eye Color; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2003 |
Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients.
Topics: Adrenergic beta-Antagonists; Arteries; Blood Pressure; Carbonic Anhydrase Inhibitors; Contrast Sensitivity; Cross-Over Studies; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Microscopy, Confocal; Middle Aged; Ophthalmoscopy; Prostaglandins F, Synthetic; Regional Blood Flow; Retinal Vessels; Sulfonamides; Thiophenes; Timolol; Veins | 2003 |
Pooled-data analysis of three randomized, double-masked, six-month studies comparing intraocular pressure-reducing effects of latanoprost and timolol in patients with ocular hypertension.
Topics: Antihypertensive Agents; Double-Blind Method; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Retrospective Studies; Timolol; Treatment Outcome | 2003 |
Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Drug Resistance; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2003 |
Efficacy of bunazosin hydrochloride 0.01% as adjunctive therapy of latanoprost or timolol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Pupil; Quinazolines; Timolol | 2004 |
A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2004 |
A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
Topics: Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 2003 |
Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma.
Topics: Aged; Antihypertensive Agents; Chronic Disease; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iridectomy; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2004 |
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2004 |
Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma.
Topics: Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol | 2004 |
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2004 |
Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol | 2004 |
Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Safety; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2004 |
A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients.
Topics: Adult; Aged; Analysis of Variance; Antihypertensive Agents; Drug Administration Schedule; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Visual Fields | 2004 |
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
Topics: Aged; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Topics: Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2005 |
A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Europe; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Timolol; Treatment Outcome | 2004 |
Daytime diurnal curve comparison between the fixed combinations of latanoprost 0.005%/timolol maleate 0.5% and dorzolamide 2%/timolol maleate 0.5%.
Topics: Adult; Aged; Antihypertensive Agents; Chronotherapy; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2004 |
Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2004 |
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Safety; Single-Blind Method; Timolol; Treatment Outcome | 2004 |
[Comparison of the effects of latanoprost and timolol gel-forming solution on diurnal variation of intraocular pressure in normal-tension glaucoma].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2004 |
Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
Topics: Adult; Aged; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Sleep; Supine Position; Timolol; Tonometry, Ocular | 2004 |
Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.
Topics: Aged; Antihypertensive Agents; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Failure; Treatment Outcome | 2004 |
Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: three-month comparison of efficacy and safety.
Topics: Cloprostenol; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol; Travoprost | 2004 |
[Short and long-term hypotensive effect of timolol-gel and latanoprost instillation in normal-tension glaucoma].
Topics: Adult; Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Time Factors; Timolol; Treatment Outcome | 2004 |
[Comparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprost].
Topics: Aged; Antihypertensive Agents; Delayed-Action Preparations; Drug Administration Schedule; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Time Factors; Timolol | 2004 |
Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Topics: Aged; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2004 |
A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
Topics: Adult; Aged; Antihypertensive Agents; Blood Flow Velocity; Cross-Over Studies; Drug Therapy, Combination; Eye; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Prostaglandins F, Synthetic; Pulsatile Flow; Regional Blood Flow; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Ultrasonography, Doppler | 2004 |
Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Chronic Disease; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Optic Disk; Optic Nerve Diseases; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Trabecular Meshwork | 2005 |
Intraocular pressure and safety in glaucoma patients switching to latanoprost/timolol maleate fixed combination from mono- and adjunctive therapies.
Topics: Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Safety; Timolol; Tonometry, Ocular; Treatment Outcome | 2004 |
Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
Topics: Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Time Factors; Timolol; Treatment Outcome | 2004 |
Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Chronic Disease; Double-Blind Method; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Trabecular Meshwork | 2005 |
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Diclofenac; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sample Size; Timolol; Tonometry, Ocular | 2005 |
Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies.
Topics: Double-Blind Method; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2005 |
Twenty-four-hour control with latanoprost-timolol-fixed combination therapy vs latanoprost therapy.
Topics: Aged; Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Prospective Studies; Prostaglandins F, Synthetic; Safety; Timolol; Tonometry, Ocular; Visual Acuity | 2005 |
The efficacy and ocular discomfort of substituting brinzolamide for dorzolamide in combination therapy with latanoprost, timolol, and dorzolamide.
Topics: Aged; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Thiophenes; Timolol; Vision, Ocular | 2005 |
A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2006 |
Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
Topics: Aged; Antihypertensive Agents; Chronic Disease; Drug Combinations; Female; Glaucoma, Angle-Closure; Humans; Instillation, Drug; Intraocular Pressure; Japan; Latanoprost; Male; Ophthalmic Solutions; Patient Compliance; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2005 |
A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Prostaglandins F, Synthetic; Regional Blood Flow; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2006 |
Comparative analysis of the efficacy and safety of latanoprost, travoprost and the fixed combination timolol-dorzolamide; a prospective, randomized, masked, cross-over design study.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Latanoprost; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Travoprost; Treatment Outcome | 2005 |
Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
Topics: Adult; Aged; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retreatment; Timolol; Treatment Outcome | 2006 |
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2006 |
An evaluation of the rate of nonresponders to latanoprost therapy.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Cross-Over Studies; Drug Resistance; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Pilocarpine; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Timolol; Tonometry, Ocular | 2006 |
Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Topics: Administration, Topical; Antihypertensive Agents; Blood Pressure; Brimonidine Tartrate; Circadian Rhythm; Diastole; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Perfusion; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2006 |
Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Cloprostenol; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Timolol; Travoprost; Visual Fields | 2006 |
A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cross-Over Studies; Double-Blind Method; Eye; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Regional Blood Flow; Sulfonamides; Thiophenes; Timolol; Visual Acuity | 2006 |
24-Hour control with a latanoprost-timolol fixed combination vs timolol alone.
Topics: Antihypertensive Agents; Circadian Rhythm; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome; Visual Acuity | 2006 |
Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Topics: Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2007 |
Retrobulbar haemodynamic effects of the latanoprost/timolol and the dorzolamide/timolol fixed combinations in newly diagnosed glaucoma patients.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Ciliary Arteries; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Artery; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2007 |
Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Visual Acuity | 2007 |
Influence of ocular hypotensive eyedrops on intraocular pressure fluctuation with postural change in eyes with normal-tension glaucoma.
Topics: Adult; Aged; Antihypertensive Agents; Cross-Over Studies; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Posture; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Visual Field Tests | 2007 |
A comparison of latanoprost monotherapy with a combination therapy of timolol/dorzolamide in patients with primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Eye Color; Eyelashes; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Prostaglandins F, Synthetic; Pruritus; Sulfonamides; Thiophenes; Timolol | 2006 |
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 2007 |
A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Middle Aged; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Treatment Outcome | 2007 |
Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma.
Topics: Administration, Topical; Aged; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; White People | 2008 |
The effect of ocular hypotensive agents on macula.
Topics: Administration, Topical; Adult; Aged; Amides; Bimatoprost; Cloprostenol; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Latanoprost; Lipids; Macula Lutea; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity; Visual Field Tests | 2007 |
Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Comorbidity; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Linear Models; Male; Middle Aged; Predictive Value of Tests; Prevalence; Prostaglandins F, Synthetic; Timolol | 2008 |
Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
Topics: Antihypertensive Agents; Circadian Rhythm; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Therapeutic Equivalency; Thiophenes; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2008 |
Dorzolamide/timolol fixed combination versus latanoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2008 |
Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2008 |
Latanoprost-induced stabilization of central visual function in patients with primary open-angle glaucoma.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Contrast Sensitivity; Cross-Over Studies; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Polysaccharides, Bacterial; Prospective Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Visual Fields | 2008 |
Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Canada; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2008 |
Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
Topics: Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Diastole; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2008 |
Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed combination in open-angle glaucoma patients.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2009 |
A comparison of dorzolamide/timolol-fixed combination versus bimatoprost in patients with open-angle glaucoma who are poorly controlled on latanoprost.
Topics: Aged; Aged, 80 and over; Amides; Bimatoprost; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2008 |
Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Topics: Antihypertensive Agents; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2008 |
Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Drug Administration Schedule; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Pain; Pilocarpine; Prostaglandins F, Synthetic; Timolol; Treatment Outcome; Vision Disorders | 2008 |
[Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
Topics: Adult; Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypotension; Prostaglandins F, Synthetic; Timolol; Travoprost | 2008 |
Intraocular pressure control with latanoprost/timolol and travoprost/timolol fixed combinations : a retrospective, multicentre, cross-sectional study.
Topics: Adult; Aged; Cloprostenol; Cross-Sectional Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Timolol; Travoprost | 2008 |
Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Blood Flow Velocity; Blood Pressure; Carteolol; Ciliary Arteries; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Artery; Ophthalmic Solutions; Optic Disk; Prostaglandins F, Synthetic; Regional Blood Flow; Retinal Artery; Timolol; Tonometry, Ocular | 2009 |
Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Cross-Over Studies; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular | 2009 |
Efficacy and safety of latanoprost in eyes with uveitic glaucoma.
Topics: Adult; Antihypertensive Agents; Drug Combinations; Female; Follow-Up Studies; Glaucoma; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Recurrence; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome; Uveitis, Anterior; Uveitis, Intermediate; Visual Acuity | 2009 |
Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Trabeculectomy; Treatment Outcome; Visual Acuity | 2009 |
24-hour intraocular pressure and blood pressure levels with latanoprost/timolol fixed combination versus timolol.
Topics: Aged; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2009 |
Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Cohort Studies; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Tears; Time Factors; Timolol; Travoprost | 2009 |
Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
Topics: Aged; Antihypertensive Agents; Circadian Rhythm; Drug Administration Schedule; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2010 |
A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Blood Pressure; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2009 |
Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Visual Acuity; Visual Fields | 2010 |
Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Visual Acuity | 2010 |
Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Topics: Antihypertensive Agents; Aqueous Humor; Cross-Over Studies; Double-Blind Method; Female; Fluorophotometry; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Sclera; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome; Uvea | 2010 |
Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prognosis; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome; Young Adult | 2010 |
The combination latanoprost-timolol versus twice daily 0.50% timolol administration either associated or not with latanoprost: efficacy and tolerability in the primary open-angle glaucoma.
Topics: Administration, Topical; Antihypertensive Agents; Drug Combinations; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Prostaglandins F, Synthetic; Time Factors; Timolol; Treatment Outcome | 2010 |
24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Exfoliation Syndrome; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Time Factors; Timolol; Travoprost | 2010 |
Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Disease Progression; Dosage Forms; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Treatment Outcome; Visual Fields | 2010 |
Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Visual Acuity | 2010 |
Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from timolol.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Vision Disorders; Visual Fields | 2011 |
Comparison of latanoprost and timolol in pediatric glaucoma: a phase 3, 12-week, randomized, double-masked multicenter study.
Topics: Adolescent; Antihypertensive Agents; Child; Child, Preschool; Double-Blind Method; Female; Glaucoma; Humans; Hydrophthalmos; Infant; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2011 |
24-Hour intraocular pressure control between travoprost/timolol fixed combination, latanoprost/ timolol fixed combination and standard timolol in primary open angle glaucoma and ocular hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cloprostenol; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Time Factors; Timolol; Travoprost; Treatment Outcome; Young Adult | 2011 |
Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; China; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Incidence; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prevalence; Prostaglandins F, Synthetic; Retrospective Studies; Time Factors; Timolol; Treatment Outcome; Young Adult | 2011 |
Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Medication Adherence; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Surveys and Questionnaires; Timolol; Tonometry, Ocular; Treatment Outcome | 2011 |
Efficacy of single glaucoma drug in combined timolol XE, latanoprost and brinzolamide therapy: a discontinuation study.
Topics: Adult; Aged; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol | 2012 |
Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Neuroprotective Agents; Optic Disk; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2012 |
Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aqueous Humor; Blood Pressure; Carbonic Anhydrase Inhibitors; Circadian Rhythm; Cornea; Cross-Over Studies; Double-Blind Method; Female; Fluorophotometry; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sphygmomanometers; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Ultrasonography | 2012 |
Efficacy of single glaucoma medication in combined latanoprost and timolol XE therapy in patients with open-angle glaucoma and ocular hypertension: a discontinuation study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Neuroprotective Agents; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Sample Size; Substance Withdrawal Syndrome; Timolol; Treatment Outcome | 2012 |
Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Time Factors; Timolol; Treatment Outcome | 2012 |
A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study.
Topics: Aged; Antihypertensive Agents; Antimetabolites, Antineoplastic; Brimonidine Tartrate; Drug Combinations; Female; Fluorouracil; Glaucoma; Humans; India; Intraocular Pressure; Latanoprost; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Surveys and Questionnaires; Thiophenes; Timolol; Tonometry, Ocular; Trabeculectomy; Visual Acuity | 2012 |
Intraocular pressure-reducing effects of latanoprost versus timolol in chinese patients with chronic angle-closure glaucoma.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Asian People; China; Chronic Disease; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Treatment Outcome; Young Adult | 2013 |
A double-masked randomized crossover study comparing the effect of latanoprost/timolol and brimonidine/timolol fixed combination on intraocular pressure and ocular blood flow in patients with primary open-angle glaucoma or ocular hypertension.
Topics: Aged; Antihypertensive Agents; Blood Flow Velocity; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Time Factors; Timolol; Ultrasonography, Doppler, Color | 2012 |
Safety and efficacy of unpreserved timolol 0.1% gel in patients controlled by preserved latanoprost with signs of ocular intolerance.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Substitution; Female; France; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Osmolar Concentration; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2013 |
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cataract; Cloprostenol; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Phacoemulsification; Postoperative Period; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost | 2013 |
24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cross-Over Studies; Double-Blind Method; Drug Combinations; Exfoliation Syndrome; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome; Visual Field Tests; Visual Fields | 2013 |
Hypotensive effect of latanoprost/timolol versus travoprost/timolol fixed combinations in NTG patients: a randomized, multicenter, crossover clinical trial.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Travoprost | 2013 |
Efficacy and safety of pneumatic trabeculoplasty versus timolol added to latanoprost in primary open angle glaucoma.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Latanoprost; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Trabeculectomy; Treatment Outcome | 2013 |
A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.
Topics: Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cross-Over Studies; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Patient Preference; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes.
Topics: Aged; Antihypertensive Agents; Cornea; Corneal Pachymetry; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2013 |
Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Eye; Female; Glaucoma, Open-Angle; HLA-DR Antigens; Humans; Immunohistochemistry; Interleukin-6; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Single-Blind Method; Timolol; Travoprost; Treatment Outcome | 2013 |
Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Healthy Volunteers; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 2014 |
Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study.
Topics: Administration, Topical; Antihypertensive Agents; Aqueous Humor; Cell Count; Conjunctiva; Cysts; Double-Blind Method; Epithelial Cells; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Microscopy, Confocal; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Visual Acuity | 2014 |
24-hour efficacy of travoprost/timolol BAK-free versus latanoprost/timolol fixed combinations in patients insufficiently controlled with latanoprost.
Topics: Antihypertensive Agents; Cross-Over Studies; Drug Combinations; Drug Monitoring; Drug Synergism; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2014 |
The Efficacy of a Latanoprost/Timolol Fixed Combination Versus Latanoprost and Timolol Gel-forming Solution Unfixed Combination on Daytime Intraocular Pressure.
Topics: Aged; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Female; Gels; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Treatment Outcome | 2016 |
Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bimatoprost; Blood Pressure; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields | 2014 |
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial.
Topics: Adult; Aged; Amides; Analysis of Variance; Antihypertensive Agents; Bimatoprost; Blood Pressure; Cloprostenol; Double-Blind Method; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol | 2015 |
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.
Topics: Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Isoquinolines; Japan; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; rho-Associated Kinases; Severity of Illness Index; Sulfonamides; Time Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2015 |
Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial.
Topics: Blood Pressure; Circadian Rhythm; Cross-Over Studies; Demography; Diastole; Drug Combinations; Female; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Perfusion; Prostaglandins F, Synthetic; Sulfonamides; Systole; Thiophenes; Timolol | 2016 |
24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Preservatives, Pharmaceutical; Prospective Studies; Prostaglandins F; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2017 |
The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP.
Topics: Aged; Aged, 80 and over; Bimatoprost; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Gonioscopy; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Monitoring, Physiologic; Prospective Studies; Prostaglandins F, Synthetic; Single-Blind Method; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2018 |
Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Japan; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Young Adult | 2018 |
Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzalkonium Compounds; Drug Combinations; Equivalence Trials as Topic; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Preservatives, Pharmaceutical; Timolol; Tonometry, Ocular; Treatment Outcome | 2019 |
MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alleles; Biomarkers; Co-Repressor Proteins; Cross-Over Studies; DNA Copy Number Variations; Female; Genome-Wide Association Study; Genotype; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Timolol | 2021 |
Corneal epithelium and limbal region alterations due to glaucoma medications evaluated by anterior segment optic coherence tomography: a case-control study.
Topics: Aged; Antihypertensive Agents; Benzalkonium Compounds; Brimonidine Tartrate; Case-Control Studies; Epithelium, Corneal; Female; Glaucoma; Humans; Latanoprost; Limbus Corneae; Male; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence | 2021 |
Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study.
Topics: Antihypertensive Agents; Carteolol; Cross-Over Studies; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2021 |
Clinical Trial: Diurnal IOP Fluctuations in Glaucoma Using Latanoprost and Timolol with Self-Tonometry.
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Manometry; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2021 |
The Effects of Topical Timolol and Latanoprost on Calculated Ocular Perfusion Pressure in Nonglaucomatous Volunteers.
Topics: Blood Pressure; Cross-Over Studies; Female; Healthy Volunteers; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Physiological Phenomena; Ophthalmic Solutions; Prospective Studies; Timolol | 2021 |
137 other study(ies) available for timolol and latanoprost
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Latanoprost--a promising new glaucoma drug.
Topics: Drug Therapy, Combination; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Timolol | 1995 |
A topical prostaglandin for glaucoma.
Topics: Administration, Topical; Adrenergic Agents; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Cholinergic Agents; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Multicenter Studies as Topic; Parasympathomimetics; Pilocarpine; Prostaglandins F, Synthetic; Timolol | 1996 |
Intraocular pressure in rabbits by telemetry II: effects of animal handling and drugs.
Topics: Animal Husbandry; Animals; Circadian Rhythm; Clonidine; Epinephrine; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Rabbits; Sulfonamides; Telemetry; Thiophenes; Timolol; Tonometry, Ocular | 1998 |
[Combined effect of topical latanoprost and timolol on retinal blood flow and tissue circulation in the optic nerve head in cynomolgus monkeys].
Topics: Animals; Female; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Optic Disk; Prostaglandins F, Synthetic; Retinal Vessels; Timolol | 2000 |
Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma; Intraocular Pressure; Latanoprost; Macaca fascicularis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Random Allocation; Sulfonamides; Thiophenes; Timolol | 2000 |
Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva.
Topics: Animals; Antihypertensive Agents; Collagen; Conjunctiva; Drug Combinations; Extracellular Matrix; Female; Immunoenzyme Techniques; Intraocular Pressure; Latanoprost; Matrix Metalloproteinase 3; Prostaglandins F, Synthetic; Rabbits; Timolol; Tissue Inhibitor of Metalloproteinase-2; Up-Regulation | 2001 |
Case reports and small case series: LASIK-associated visual field loss in a glaucoma suspect.
Topics: Cornea; Female; Humans; Intraocular Pressure; Keratomileusis, Laser In Situ; Latanoprost; Middle Aged; Myopia; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Vision Disorders; Visual Acuity; Visual Fields | 2001 |
Reliable measurement of mouse intraocular pressure by a servo-null micropipette system.
Topics: Acetazolamide; Anesthetics, Local; Animals; Aqueous Humor; Electrophysiology; Female; Intraocular Pressure; Latanoprost; Male; Mice; Ophthalmology; Pilocarpine; Prostaglandins F, Synthetic; Reproducibility of Results; Timolol | 2001 |
[Change in the pH of aqueous humor after administration of anti-glaucoma agents in rabbits in vivo].
Topics: Animals; Aqueous Humor; Glaucoma; Hydrogen-Ion Concentration; Latanoprost; Male; Pilocarpine; Prostaglandins F, Synthetic; Rabbits; Timolol | 2001 |
[Additive effects of topical carbonic anhydrase inhibitors].
Topics: Aged; Betaxolol; Carbonic Anhydrase Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pilocarpine; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2001 |
Corneal effects of latanoprost and timolol.
Topics: Antihypertensive Agents; Cell Count; Cornea; Endothelium, Corneal; Humans; Latanoprost; Prostaglandins F, Synthetic; Timolol | 2001 |
[The pH reaction in aqueous humor to antiglaucoma agents of various concentrations and pH levels].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Aqueous Humor; Female; Glaucoma; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Latanoprost; Male; Middle Aged; Pilocarpine; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2001 |
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Topics: Antihypertensive Agents; Clinical Trials as Topic; Cloprostenol; Drug Evaluation; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Safety; Timolol; Travoprost | 2002 |
Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy.
Topics: Absorption; Aged; Aqueous Humor; Biological Availability; Drug Combinations; Eye; Female; Half-Life; Humans; Intraocular Pressure; Latanoprost; Male; Prostaglandins F, Synthetic; Time Factors; Timolol | 2002 |
Effect of Xalatan(R) and Cosopt(R) on the vascular tone of quiescent isolated pig ciliary arteries.
Topics: Animals; Antihypertensive Agents; Ciliary Arteries; Culture Techniques; Dose-Response Relationship, Drug; Drug Combinations; Intraocular Pressure; Latanoprost; Potassium Chloride; Prostaglandins F, Synthetic; Sulfonamides; Swine; Thiophenes; Timolol; Vasoconstriction | 2002 |
Effect of hyaluronic acid on intraocular pressure in rats.
Topics: Animals; Anterior Chamber; Antihypertensive Agents; Brimonidine Tartrate; Disease Models, Animal; Hyaluronic Acid; Injections; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Timolol; Tonometry, Ocular | 2002 |
Discontinuation rates of topical glaucoma medications in a managed care population.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Brimonidine Tartrate; Chi-Square Distribution; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Proportional Hazards Models; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Survival Analysis; Timolol | 2002 |
Primary glaucoma in Burmese cats.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Breeding; Cat Diseases; Cats; Female; Glaucoma; Latanoprost; Ophthalmic Solutions; Prednisolone; Prostaglandins F, Synthetic; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 2002 |
Evaluation of the intraocular pressure-reducing effect of latanoprost as monotherapy in open-angle glaucoma.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2002 |
Nurse prescribing in glaucoma.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Clinical Competence; Clinical Protocols; Drug Prescriptions; England; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Nurse Practitioners; Nursing Audit; Nursing Staff, Hospital; Outpatient Clinics, Hospital; Prostaglandins F, Synthetic; Timolol | 2003 |
Vitrectomy for phacolytic glaucoma in a patient with ectopia lentis et pupillae.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Ectopia Lentis; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Vitrectomy | 2003 |
[Drug therapy for residual angle-closure glaucoma after laser iridectomy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Administration Schedule; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Iridectomy; Laser Therapy; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Prostaglandins F, Synthetic; Timolol | 2002 |
Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Child; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Neuroprotective Agents; Physicians' Offices; Practice Patterns, Physicians'; Prostaglandins F, Synthetic; Sulfonamides; Switzerland; Thiophenes; Timolol; Treatment Outcome | 2003 |
Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol.
Topics: Antihypertensive Agents; Benzalkonium Compounds; Cell Line, Transformed; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Interleukin-1; Interleukin-6; Latanoprost; Lens, Crystalline; Microscopy, Phase-Contrast; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Radioimmunoassay; Timolol | 2003 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |
The free amino acids and the aqueous humor pH after antiglaucomatics in vitro.
Topics: Aged; Aged, 80 and over; Amino Acids; Animals; Antihypertensive Agents; Aqueous Humor; Carbonic Anhydrase Inhibitors; Female; Glaucoma; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Latanoprost; Male; Middle Aged; Pilocarpine; Prostaglandins F, Synthetic; Rabbits; Sulfonamides; Thiophenes; Timolol | 2003 |
ESCRS Binkhorst lecture 2002: Pseudophakic preservative maculopathy.
Topics: Aqueous Humor; Cataract Extraction; Humans; Incidence; Inflammation; Intraocular Pressure; Latanoprost; Macular Edema; Ophthalmic Solutions; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Pseudophakia; Timolol | 2003 |
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Proteins; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol | 2003 |
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.
Topics: Adolescent; Aged; Annexin A5; Antihypertensive Agents; Apoptosis; Benzalkonium Compounds; Betaxolol; Biomarkers; Cells, Cultured; DNA; Humans; Latanoprost; Male; Membrane Proteins; Microscopy, Confocal; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol; Trabecular Meshwork | 2003 |
Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Contraindications; Databases, Factual; Drug Prescriptions; Female; Glaucoma; Humans; Latanoprost; Male; Middle Aged; National Health Programs; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quebec; Quinoxalines; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 2003 |
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Keratitis; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Risk Factors; Sulfonamides; Tears; Thiophenes; Timolol | 2003 |
Persistency with latanoprost or timolol in primary open-angle glaucoma suspects.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Cohort Studies; Drug Prescriptions; Drug Utilization; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Managed Care Programs; Middle Aged; Ophthalmic Solutions; Patient Compliance; Prostaglandins F, Synthetic; Retrospective Studies; Timolol | 2004 |
Brimonidine and latanoprost as adjunctive therapy.
Topics: Antihypertensive Agents; Brimonidine Tartrate; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2004 |
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Apoptosis; Benzalkonium Compounds; Case-Control Studies; Cell Line; Cell Survival; Conjunctiva; Female; Flow Cytometry; Glaucoma, Open-Angle; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Latanoprost; Male; Middle Aged; Mucin 5AC; Mucins; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol | 2004 |
Inhibitory effects of anti-glaucoma drugs on corneal epithelial migration in a rabbit organ culture system.
Topics: Animals; Antihypertensive Agents; Cell Movement; Dose-Response Relationship, Drug; Epithelium, Corneal; Latanoprost; Organ Culture Techniques; Propanolamines; Prostaglandins F, Synthetic; Rabbits; Timolol; Wound Healing | 2004 |
Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United Kingdom.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Chronic Disease; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Miotics; Prostaglandins F, Synthetic; Risk Factors; Sympathomimetics; Timolol; Treatment Failure | 2004 |
[Measurement of corneal thickness in cases where tonometry is contraindicated].
Topics: Antihypertensive Agents; Computer Graphics; Corneal Topography; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Manometry; Middle Aged; Optic Disk; Prostaglandins F, Synthetic; Signal Processing, Computer-Assisted; Sulfonamides; Thiophenes; Timolol; Visual Fields | 2004 |
Tales of two drugs.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Drug Design; Glaucoma; History, 20th Century; History, 21st Century; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Pharmaceutical Preparations; Pharmacology; Prostaglandins F, Synthetic; Timolol | 2005 |
Cost considerations of the new fixed combinations for glaucoma medical therapy.
Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Canada; Drug Combinations; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol | 2005 |
How to control measurement variation in estimating the mean intraocular pressure reducing effect at a specific point in time.
Topics: Antihypertensive Agents; Functional Laterality; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Models, Statistical; Multicenter Studies as Topic; Ocular Hypertension; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Research Design; Sample Size; Time Factors; Timolol; Tonometry, Ocular | 2005 |
An uncommon presentation of acute angle closure glaucoma.
Topics: Acetazolamide; Acute Disease; Analgesics; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Follow-Up Studies; Glaucoma, Angle-Closure; Headache; Humans; Latanoprost; Male; Middle Aged; Miotics; Pilocarpine; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2005 |
Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Aqueous Humor; Case-Control Studies; Gelatinases; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Timolol; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops.
Topics: Antihypertensive Agents; Female; Glaucoma; Humans; Latanoprost; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Stevens-Johnson Syndrome; Sulfonamides; Thiophenes; Timolol | 2005 |
The state of being noninferior.
Topics: Antihypertensive Agents; Choroidal Neovascularization; Clinical Trials as Topic; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Macular Degeneration; Photochemotherapy; Practice Guidelines as Topic; Pregnadienediols; Prostaglandins F, Synthetic; Research Design; Timolol | 2006 |
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Controlled Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Costs; Economics, Pharmaceutical; Europe; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Lipids; Models, Econometric; Prostaglandins F, Synthetic; Timolol | 2006 |
[Effect of topical glaucoma medications on optic disc topography in normal tension glaucoma].
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Ophthalmoscopy; Optic Disk; Prostaglandins F, Synthetic; Timolol | 2006 |
Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts.
Topics: Aged; Antihypertensive Agents; Cells, Cultured; Collagen Type I; Contracture; Corneal Stroma; Dose-Response Relationship, Drug; Female; Fibroblasts; Gels; Humans; Hydroxyproline; L-Lactate Dehydrogenase; Latanoprost; Male; Middle Aged; Pilocarpine; Prostaglandins F, Synthetic; Time Factors; Timolol; Vimentin | 2006 |
Effects of topical antiglaucoma application on conjunctival impression cytology specimens.
Topics: Administration, Topical; Antihypertensive Agents; Conjunctiva; Cross-Sectional Studies; Drug Therapy, Combination; Epithelium; Glaucoma, Open-Angle; Humans; Latanoprost; Metaplasia; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2006 |
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
Topics: Administration, Topical; Aged; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Carteolol; Case-Control Studies; Chemokines; Cloprostenol; Cytokines; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Tears; Thiophenes; Timolol | 2007 |
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
Topics: Animals; Antihypertensive Agents; Cell Death; Dose-Response Relationship, Drug; Latanoprost; Mast Cells; Prostaglandins F, Synthetic; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Timolol; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2006 |
Comments on The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Europe; Glaucoma, Open-Angle; Humans; Latanoprost; Lipids; Prostaglandins F, Synthetic; Timolol | 2006 |
The state of being noninferior.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2006 |
Hypotony and choroidal detachment as a complication of topical combined timolol and dorzolamide.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Cataract Extraction; Choroid Diseases; Chronic Disease; Drug Interactions; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Middle Aged; Ocular Hypotension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Recurrence; Sulfonamides; Thiophenes; Timolol; Trabeculectomy | 2007 |
[Glaucoma--the underestimated risk].
Topics: Antihypertensive Agents; Child; Early Diagnosis; Glaucoma; Humans; Latanoprost; Nursing Diagnosis; Ophthalmic Solutions; Prostaglandins F, Synthetic; Referral and Consultation; Timolol; Visual Fields | 2007 |
Drug modification of angiogenesis in a rat cornea model.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Corneal Neovascularization; Corneal Stroma; Disease Models, Animal; Drug Implants; Fibroblast Growth Factor 2; Latanoprost; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Sulfonamides; Thiophenes; Timolol | 2008 |
Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Topics: Adrenal Cortex Hormones; Animals; Anterior Chamber; Cholinergic Agonists; Conjunctival Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glaucoma; Instillation, Drug; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Pilocarpine; Prednisolone; Prostaglandins F, Synthetic; Rabbits; Timolol; Tonometry, Ocular; Treatment Outcome | 2007 |
A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
Topics: Adrenergic beta-Antagonists; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Europe; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Models, Economic; Prostaglandins F, Synthetic; Prostaglandins, Synthetic; Timolol; Travoprost | 2008 |
Estimation of ocular rigidity based on measurement of pulse amplitude using pneumotonometry and fundus pulse using laser interferometry in glaucoma.
Topics: Aged; Blood Pressure; Drug Therapy, Combination; Female; Fundus Oculi; Glaucoma, Open-Angle; Humans; Interferometry; Intraocular Pressure; Lasers; Latanoprost; Light; Male; Middle Aged; Prostaglandins F, Synthetic; Pulse; Reference Values; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular | 2008 |
Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Patient Compliance; Patient Satisfaction; Prostaglandins F, Synthetic; Sulfonamides; Surveys and Questionnaires; Thiophenes; Timolol | 2008 |
Performing meta-analysis with incomplete statistical information in clinical trials.
Topics: Antihypertensive Agents; Cholesterol, LDL; Clinical Trials as Topic; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Intraocular Pressure; Latanoprost; Meta-Analysis as Topic; Metformin; Ocular Hypertension; Prostaglandins F, Synthetic; Sampling Studies; Sulfonylurea Compounds; Thiazolidinediones; Time Factors; Timolol | 2008 |
Changes in intraocular pressure following a switch from latanoprost monotherapy to latanoprost/timolol fixed combination therapy in patients with primary open-angle glaucoma or ocular hypertension: results from a clinical practice database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Databases, Factual; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Retrospective Studies; Timolol | 2008 |
Effect of latanoprost and timolol on the histopathology of the human conjunctiva.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antihypertensive Agents; Biopsy; Collagen; Conjunctiva; Extracellular Matrix; Glaucoma, Open-Angle; Humans; Latanoprost; Matrix Metalloproteinases; Microscopy, Electron, Scanning; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tissue Inhibitor of Metalloproteinases | 2009 |
Anterior uveitis associated with fixed-combination latanoprost and timolol.
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol; Uveitis, Anterior | 2008 |
Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.
Topics: Aged; Antihypertensive Agents; Cloprostenol; Cost-Benefit Analysis; Databases, Factual; Drug Combinations; Female; Glaucoma; Humans; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Physicians, Family; Prostaglandins F, Synthetic; Timolol; Travoprost; United Kingdom | 2009 |
An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Benzalkonium Compounds; Cell Count; Cornea; Drug Combinations; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Microscopy, Confocal; Middle Aged; Ocular Hypertension; Ophthalmic Nerve; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Retrospective Studies; Timolol | 2009 |
Cost effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom using a decision-analytic health economic model.
Topics: Antihypertensive Agents; Cost-Benefit Analysis; Glaucoma; Humans; Latanoprost; Markov Chains; Prostaglandins F, Synthetic; Scandinavian and Nordic Countries; Timolol; United Kingdom | 2009 |
Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK.
Topics: Acetazolamide; Administration, Topical; Adrenergic beta-Antagonists; Amides; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Intraocular Pressure; Latanoprost; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscarinic Agonists; Pilocarpine; Prostaglandins F, Synthetic; Pyridines; rho-Associated Kinases; Timolol | 2009 |
Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Drug Administration Schedule; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Respiration; Spirometry; Timolol; Treatment Outcome | 2009 |
Corneal thickness and glaucoma medications.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Cornea; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Relative efficacy of prostaglandins.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Circadian Rhythm; Cloprostenol; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Randomized Controlled Trials as Topic; Single-Blind Method; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome | 2009 |
Efficiency of travoprost versus fixed-combination latanoprost/timolol.
Topics: Antihypertensive Agents; Cloprostenol; Drug Combinations; Glaucoma; Humans; Latanoprost; Ocular Hypotension; Prostaglandins F, Synthetic; Timolol; Travoprost; Treatment Failure | 2009 |
Smoothing the intraocular pressure roller coaster: a new goal?
Topics: Antihypertensive Agents; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Patient Compliance; Prostaglandins F, Synthetic; Risk Factors; Timolol; Tonometry, Ocular; Treatment Outcome | 2009 |
Aerobic exercise and intraocular pressure in normotensive and glaucoma patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Exercise; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Quinoxalines; Timolol | 2009 |
Experimental model of ocular hypertension in the rat: study of the optic nerve capillaries and action of hypotensive drugs.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Capillaries; Disease Models, Animal; Glucose Transporter Type 1; Immunoenzyme Techniques; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Optic Disk; Optic Nerve; Prostaglandins F, Synthetic; Rats; Rats, Wistar; Timolol | 2010 |
[Atypical unilateral glaucoma in a young patient].
Topics: Adolescent; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Filtering Surgery; Glaucoma, Open-Angle; Humans; Latanoprost; Male; Optic Disk; Prostaglandins F, Synthetic; Timolol; Tomography, Optical Coherence; Visual Fields | 2010 |
Surface tension of aqueous humor.
Topics: Animals; Antihypertensive Agents; Aqueous Humor; Cataract; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Rabbits; Surface Tension; Timolol | 2010 |
Absence of corneal endothelium injury in non-human primates treated with and without ophthalmologic drugs and exposed to 2.8 GHz pulsed microwaves.
Topics: Animals; Body Temperature; Endothelium, Corneal; Latanoprost; Macaca mulatta; Male; Microwaves; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol | 2010 |
Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Disease Models, Animal; Glaucoma; Glial Fibrillary Acidic Protein; Gliosis; Intraocular Pressure; Latanoprost; Male; Neuroglia; Prostaglandins F, Synthetic; Quinoxalines; Rats; Rats, Wistar; Retina; Timolol; Tonometry, Ocular | 2010 |
Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma.
Topics: Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brimonidine Tartrate; Drug Therapy, Combination; Eye Neoplasms; Female; Glaucoma; Humans; Latanoprost; Loteprednol Etabonate; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Parotid Neoplasms; Prostaglandins F, Synthetic; Quinoxalines; Rituximab; Sulfonamides; Thiophenes; Timolol | 2010 |
Impact of once daily versus twice daily application of adjunctive timolol on the intraocular pressure-lowering effect of latanoprost.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Optic Nerve Diseases; Prostaglandins F, Synthetic; Timolol | 2010 |
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
Topics: Adult; Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Blindness; Cost-Benefit Analysis; Decision Trees; Drug Costs; Female; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Models, Theoretical; Ocular Hypertension; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular | 2012 |
Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Glaucoma; Heart Rate; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Reference Values; Species Specificity; Tears; Timolol | 2010 |
Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Treatment Outcome; Visual Fields; Young Adult | 2010 |
Effectiveness of dorzolamide–timolol (COSOPT) in patients who were treatment naive for open-angle glaucoma or ocular hypertension: the COSOPT first-line study.
Topics: Aged; Drug Combinations; Eye; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Multicenter Studies as Topic; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2010 |
Hyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapy.
Topics: Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Drug Combinations; Follow-Up Studies; Glaucoma; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Longitudinal Studies; Prostaglandins F, Synthetic; Time Factors; Timolol; Travoprost | 2010 |
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension.
Topics: Adult; Antihypertensive Agents; Blindness; Brimonidine Tartrate; Decision Trees; Disease Progression; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Markov Chains; Middle Aged; Models, Biological; Monte Carlo Method; Ocular Hypertension; Prostaglandins F, Synthetic; Quinoxalines; Risk Assessment; Sulfonamides; Thiophenes; Timolol | 2011 |
In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Topics: Apoptosis; Benzalkonium Compounds; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Clone Cells; Cloprostenol; Conjunctiva; Drug Combinations; Epithelial Cells; Humans; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Oxidative Stress; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Superoxides; Sympatholytics; Timolol; Travoprost | 2011 |
Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
Topics: Animals; Anti-Bacterial Agents; Antihypertensive Agents; Benzalkonium Compounds; Cell Survival; Cloprostenol; Conjunctiva; Disease Models, Animal; Drug Combinations; Epithelium, Corneal; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Rabbits; Timolol; Travoprost; Treatment Outcome | 2011 |
[Comparison of primary medicament therapy effects and primary argon laser trabeculoplasty on regulation of intraocular pressure and stability of perimetry findings in open angle glaucoma].
Topics: Aged; Antihypertensive Agents; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser Therapy; Lasers, Gas; Latanoprost; Male; Middle Aged; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Trabeculectomy; Visual Field Tests | 2011 |
[In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
Topics: Antihypertensive Agents; Cells, Cultured; Cloprostenol; Cornea; Drug Combinations; Epithelial Cells; Glaucoma; Humans; In Vitro Techniques; Latanoprost; Mannitol; Ophthalmic Solutions; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol; Travoprost | 2011 |
Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Cloprostenol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Posture; Prostaglandins F, Synthetic; Quinoxalines; Retrospective Studies; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular; Travoprost | 2011 |
Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Topics: Antihypertensive Agents; Apoptosis; Benzalkonium Compounds; Cell Survival; Cells, Cultured; Cloprostenol; Drug Combinations; Fluoresceins; Glaucoma; Humans; Latanoprost; Matrix Metalloproteinase 9; Polymers; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol; Trabecular Meshwork; Travoprost | 2011 |
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Topics: Aged; Amides; Antihypertensive Agents; Bimatoprost; Cloprostenol; Disease Progression; Drug Costs; Europe; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prostaglandins F, Synthetic; Retrospective Studies; Time Factors; Timolol; Travoprost; Treatment Outcome | 2011 |
A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry.
Topics: Antihypertensive Agents; Benzalkonium Compounds; Chromatography, High Pressure Liquid; Drug Combinations; Drug Contamination; Drug Stability; Drug Storage; Drugs, Generic; Glaucoma; Latanoprost; Prescription Drugs; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Sulfonamides; Tandem Mass Spectrometry; Thiophenes; Timolol | 2012 |
The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma.
Topics: Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Cost-Benefit Analysis; Decision Support Techniques; Disease Progression; Drug Costs; Economics, Pharmaceutical; Follow-Up Studies; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quality-Adjusted Life Years; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2012 |
Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cloprostenol; Drug Combinations; Drug Substitution; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Surveys and Questionnaires; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Young Adult | 2012 |
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma.
Topics: Animals; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Feasibility Studies; Intraocular Pressure; Latanoprost; Mice; Mice, Inbred C57BL; Microspheres; Muscarinic Agonists; Ocular Hypertension; Optic Nerve; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Retinal Ganglion Cells; Sulfonamides; Thiazines; Timolol; Tomography, Optical Coherence | 2012 |
Treatment of negative dysphotopsia with unique sulcus lens.
Topics: Aged; Antihypertensive Agents; Cataract; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Latanoprost; Lens Implantation, Intraocular; Lenses, Intraocular; Phacoemulsification; Prostaglandins F, Synthetic; Timolol; Vision Disorders; Visual Acuity | 2012 |
[The rabbit's IOP values after instillation of the L-arginine HCL with selected antiglaucomatic drugs mixtures prepared in vitro. (comparative study of results of the experimental works)].
Topics: Animals; Antihypertensive Agents; Arginine; Drug Combinations; Female; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Rabbits; Sulfonamides; Thiophenes; Timolol | 2012 |
Novel usage of intraocular pressure-lowering drugs as wound-healing inhibitors after trabeculectomy with cell culture and animal models.
Topics: Animals; Aqueous Humor; Benzalkonium Compounds; Biomarkers; Cell Culture Techniques; Cell Movement; Cell Proliferation; Collagen; Dinoprost; Fibroblasts; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Proliferating Cell Nuclear Antigen; Prostaglandins F, Synthetic; Rabbits; Timolol; Trabeculectomy; Wound Healing | 2013 |
[Contribution focused to clarify correlation between mixtures of the free amino acids with antiglaucomatics in influencing the IOP in rabbits after application into the conjunctival sac].
Topics: Animals; Antihypertensive Agents; Arginine; Drug Combinations; Female; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Prostaglandins F, Synthetic; Rabbits; Sulfonamides; Thiophenes; Timolol | 2013 |
A decrease of the rabbit's physiologic IOP after the application of specific amino acids and double combination of antiglaucomatics mixture.
Topics: Animals; Antihypertensive Agents; Arginine; Drug Combinations; Female; Intraocular Pressure; Latanoprost; Prostaglandins F, Synthetic; Rabbits; Sulfonamides; Taurine; Thiophenes; Timolol | 2013 |
Managing advanced unilateral pseudoexfoliative glaucoma.
Topics: Antihypertensive Agents; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Exfoliation Syndrome; Glaucoma, Open-Angle; Humans; Hypertrichosis; Intraocular Pressure; Iris Diseases; Latanoprost; Male; Middle Aged; Pigmentation Disorders; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol; Trabeculectomy | 2014 |
Early and frequent development of ocular hypertension in children with nephrotic syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Antihypertensive Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Intraocular Pressure; Latanoprost; Male; Nephrotic Syndrome; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Prevalence; Prostaglandins F, Synthetic; Recurrence; Retrospective Studies; Timolol | 2014 |
A prospective research study of anti-glaucoma drugs prescribing, utilization pattern and adverse drug reaction recording in a university hospital.
Topics: Acetazolamide; Adult; Adverse Drug Reaction Reporting Systems; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Glaucoma; Hospitals, University; Humans; Latanoprost; Male; Middle Aged; Prospective Studies; Prostaglandins F, Synthetic; Sulfonamides; Thiophenes; Timolol | 2015 |
Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs.
Topics: Animals; Antihypertensive Agents; Brimonidine Tartrate; Catalase; Dexamethasone; Disease Models, Animal; Female; Glutathione; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Oxidative Stress; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Rats, Sprague-Dawley; Retina; Sulfonamides; Superoxide Dismutase; Thiophenes; Timolol | 2015 |
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis.
Topics: Antihypertensive Agents; Drug Combinations; Female; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Retrospective Studies; Timolol; Tonometry, Ocular; Travoprost; Treatment Outcome; Uveitis | 2017 |
Strategies to estimate the characteristics of 24-hour IOP curves of treated glaucoma patients during office hours.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Circadian Rhythm; Drug Combinations; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Office Visits; Physicians' Offices; Posture; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular | 2016 |
Neuroprotective Effect of Ocular Hypotensive Drugs: Latanoprost/Timolol in Combination Are More Effective than Each as Monotherapy in RGC-5.
Topics: Animals; Antihypertensive Agents; Cell Death; Cell Line; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endoplasmic Reticulum; Latanoprost; Mice; Oxidative Stress; Prostaglandins F, Synthetic; Retina; Timolol | 2016 |
Determination of phosphate concentration in glaucoma eye drops commercially available in Spain.
Topics: Brimonidine Tartrate; Buffers; Drugs, Generic; Glaucoma; Humans; Hydrogen-Ion Concentration; Latanoprost; Ophthalmic Solutions; Phosphates; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Spain; Spectrophotometry, Ultraviolet; Timolol | 2016 |
In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide.
Topics: Animals; Brimonidine Tartrate; Cell Survival; Electric Impedance; Epithelium, Corneal; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Prostaglandins F, Synthetic; Rabbits; Safety; Sulfonamides; Thiazines; Thiophenes; Timolol | 2016 |
Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
Topics: Animals; Antihypertensive Agents; Area Under Curve; Cell Line; Chromatography, Liquid; Disease Models, Animal; Drug Combinations; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Metabolic Clearance Rate; Ocular Hypertension; Prostaglandins F; Prostaglandins F, Synthetic; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Time Factors; Timolol; Treatment Outcome | 2016 |
Effect of prophylactic topical hypotensive medications in reducing the incidence of postoperative ocular hypertension after phacoemulsification in dogs.
Topics: Administration, Topical; Animals; Dog Diseases; Dogs; Female; Incidence; Intraocular Pressure; Latanoprost; Male; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Pre-Exposure Prophylaxis; Prostaglandins F, Synthetic; Retrospective Studies; Sulfonamides; Thiophenes; Timolol | 2017 |
Assessment of the Anterior Chamber Flare and Macular Thickness in Patients Treated with Topical Antiglaucomatous Drugs.
Topics: Administration, Topical; Anterior Chamber; Antihypertensive Agents; Bimatoprost; Female; Glaucoma; Humans; Latanoprost; Macular Degeneration; Male; Middle Aged; Prostaglandins F, Synthetic; Timolol | 2017 |
Pure Glaucoma Drugs Are Toxic to Immortalized Human Corneal Epithelial Cells, but They Do Not Destabilize Lipid Membranes.
Topics: Antihypertensive Agents; Apoptosis; Brimonidine Tartrate; Cell Line; Cell Membrane; Cell Survival; Electrophoresis, Capillary; Epithelium, Corneal; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Liposomes; Membrane Lipids; Ocular Hypertension; Pilocarpine; Prostaglandins F, Synthetic; Sulfonamides; Thiazines; Timolol | 2017 |
Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.
Topics: Amides; Animals; Anterior Eye Segment; Antihypertensive Agents; Aqueous Humor; Cromakalim; Drug Synergism; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Latanoprost; Male; Mice; Mice, Inbred C57BL; Middle Aged; Ophthalmic Solutions; Prodrugs; Prostaglandins F, Synthetic; Pyridines; Rabbits; Sclera; Timolol; Tonometry, Ocular; Venous Pressure | 2017 |
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure.
Topics: Administration, Ophthalmic; Adult; Antihypertensive Agents; Blood Flow Velocity; Drug Combinations; Female; Flavonoids; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Microcirculation; Middle Aged; Oxidative Stress; Prostaglandins F, Synthetic; Retina; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2017 |
Meibomian Gland Features and Conjunctival Goblet Cell Density in Glaucomatous Patients Controlled With Prostaglandin/Timolol Fixed Combinations: A Case Control, Cross-sectional Study.
Topics: Aged; Antihypertensive Agents; Bimatoprost; Case-Control Studies; Cell Count; Conjunctiva; Cross-Sectional Studies; Drug Combinations; Female; Glaucoma; Goblet Cells; Humans; Intraocular Pressure; Latanoprost; Male; Meibomian Glands; Microscopy, Confocal; Middle Aged; Prostaglandins F, Synthetic; Timolol; Tonometry, Ocular; Travoprost | 2018 |
Association of Postoperative Topical Prostaglandin Analog or Beta-Blocker Use and Incidence of Pseudophakic Cystoid Macular Edema.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Bimatoprost; Case-Control Studies; Cataract; Cataract Extraction; Combined Modality Therapy; Female; Humans; Incidence; Intraocular Pressure; Latanoprost; Macular Edema; Male; Middle Aged; Postoperative Complications; Postoperative Period; Prostaglandins, Synthetic; Pseudophakia; Timolol; Travoprost | 2018 |
Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Aged, 80 and over; Brimonidine Tartrate; Conjunctivitis, Allergic; Cyclopentolate; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Granuloma; Humans; Latanoprost; Lubricant Eye Drops; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Sulfonamides; Thiophenes; Timolol; Uveitis, Anterior | 2018 |
A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery.
Topics: Administration, Ophthalmic; Antihypertensive Agents; Costs and Cost Analysis; Cross-Sectional Studies; Drug Costs; Female; Glaucoma; Global Health; Health Services Accessibility; Humans; Income; Intraocular Pressure; Laser Coagulation; Latanoprost; Male; Middle Aged; Timolol; Trabeculectomy | 2018 |
Consultation Section: Glaucoma. Management of cataract and glaucoma in patient with a preexisting Cypass microstent in fellow eye: January consultation #1.
Topics: Aged; Antihypertensive Agents; Cataract; Drug Combinations; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Male; Ophthalmic Solutions; Optic Disk; Referral and Consultation; Retinal Pigment Epithelium; Sulfonamides; Thiophenes; Timolol; Tomography, Optical Coherence; Visual Fields | 2019 |
An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
Topics: Amides; Cicatrix; Collagen; Fibroblasts; Humans; Latanoprost; Pyridines; rho-Associated Kinases; Signal Transduction; Tenon Capsule; Timolol; Transforming Growth Factor beta | 2019 |
Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
Topics: Bimatoprost; Cost-Benefit Analysis; Glaucoma, Open-Angle; Health Care Costs; Humans; Intraocular Pressure; Latanoprost; Patient Preference; Prostaglandins F; Timolol; Travoprost; Visual Acuity | 2019 |
Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol.
Topics: Animals; Antihypertensive Agents; Carteolol; Cell Line; Drug Combinations; Epithelium, Corneal; Humans; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Prostaglandins F; Timolol | 2019 |
Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
Topics: Animals; Antihypertensive Agents; Contact Lenses; Drug Carriers; Drug Combinations; Drug Delivery Systems; Glaucoma; Intraocular Pressure; Latanoprost; Male; Micelles; Polyethylene Glycols; Polyglutamic Acid; Rabbits; Timolol | 2019 |
Comparison of Two Combinations of Maximum Medical Therapy for Lowering Intraocular Pressure in Primary Open-angle Glaucoma.
Topics: Adult; Aged; Antihypertensive Agents; Brimonidine Tartrate; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Sulfonamides; Thiophenes; Timolol; Treatment Outcome | 2020 |
Reversible Corneal Endothelial Abnormalities With Netarsudil.
Topics: Aged; Antihypertensive Agents; Benzoates; beta-Alanine; Corneal Diseases; Drug Therapy, Combination; Endothelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Remission Induction; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Withholding Treatment | 2020 |
Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma.
Topics: Antihypertensive Agents; Double-Blind Method; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2020 |
Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment.
Topics: Adult; Antihypertensive Agents; Bimatoprost; Drug Combinations; Glaucoma; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins A; Prostaglandins F; Timolol; Travoprost | 2022 |
[Fixed combination of latanoprost and timolol in the long-term treatment of patients with normal-tension glaucoma].
Topics: Antihypertensive Agents; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Low Tension Glaucoma; Ocular Hypertension; Prostaglandins F, Synthetic; Quality of Life; Timolol; Treatment Outcome | 2022 |
A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma.
Topics: Animals; Antihypertensive Agents; Glaucoma; Hydrogels; Intraocular Pressure; Lacrimal Apparatus; Latanoprost; Micelles; Ocular Hypertension; Prostaglandins F, Synthetic; Quality of Life; Rabbits; Timolol; Treatment Outcome | 2023 |
Primary Open-Angle Glaucoma Progression in Glaucoma Patients with Unchanged Topical Treatment over 3 Years - Retrospective Observational Cohort Analysis.
Topics: Administration, Topical; Antihypertensive Agents; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ophthalmic Solutions; Retinal Ganglion Cells; Retrospective Studies; Timolol; Travoprost | 2023 |
Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
Topics: Animals; Antiglaucoma Agents; Cicatrix; Collagen; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Latanoprost; Mice; Protein Kinase Inhibitors; rho-Associated Kinases; Timolol; Transforming Growth Factor beta; Vimentin | 2023 |
Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye.
Topics: Adolescent; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Latanoprost; Methazolamide; Middle Aged; Timolol; Treatment Outcome; United States | 2023 |